ellen m. lavoie smith, phd, msn, rn, aocn®, faan education

Ellen Lavoie Smith Last Revised 2/27/2020 1

Ellen M. Lavoie Smith, PhD, MSN, RN, AOCN®, FAAN

University of Michigan School of Nursing

Suite 2151; 400 North Ingalls Street

Ann Arbor, MI 48109

734-936-1267

[email protected]

EDUCATION AND TRAINING

1982 Bachelor of Science in Nursing, University of Vermont, Burlington, VT

1991 Master of Science, Nursing, University of New Hampshire, Durham, NH

1997 Post-graduate Nurse Practitioner Certification, University of New Hampshire,

Durham, NH

2008 PhD, University of Utah, Salt Lake City, UT

CERTIFICATION AND LICENSURE

Vermont RN 026-0026849, 1982 (not renewed as of 2003)

Vermont Adult Nurse Practitioner Licensures in Vermont, 101-0026849, 1982 (not renewed as of 2003)

New Hampshire RN 025381-21, 1993 (not renewed as of 2010)

New Hampshire Adult Nurse Practitioner Licensures 025381-23-05, 1993 (not renewed as of 2010)

Board Certification – Advanced Practice Registered Nurse, 1997

Michigan RN Licensure 4704272442, 2009

Michigan Adult Nurse Practitioner Licensure 470272442, 2009-2016

Advanced Oncology Nurse Certification, 1994-present

ACADEMIC, ADMINISTRATIVE, AND CLINICAL APPOINTMENTS

Academic Appointments

1991-2008 Clinical Instructor, Dartmouth Medical School, Hanover, New Hampshire

2008 Assistant Professor, Dartmouth Medical School, Hanover, New Hampshire

2009- 2015 Assistant Professor, University of Michigan School of Nursing – Division of Acute,

Critical and Long Term Care

2015- PhD Program Director, University of Michigan School of Nursing

2015-2017 Faculty Senate Representative (Elected) - University of Michigan

2015-2019 Associate Professor with Tenure, University of Michigan School of Nursing –

Department of Health Behavior and Biologic Sciences

2016-2018 Chair of the Faculty (Elected), University of Michigan School of Nursing

2018-2021 Executive Committee (Elected), University of Michigan School of Nursing

2018-present Adjunct Associate Professor, Hariri School of Nursing, American University of Beirut

2019, Sept. Professor with Tenure, University of Michigan School of Nursing – Department of

Health Behavior and Biologic Sciences

Hospital/Clinic Appointments

1982-1984 Oncology Staff/ Assistant Head Nurse, Dartmouth-Hitchcock Medical Center,

Hanover, New Hampshire

1984 Oncology Staff Nurse, Intensive Care Leukemia Unit, The Johns Hopkins

Medical Center, Baltimore, Maryland

1984-1986 Oncology Nurse Coordinator, Columbia Medical Plan, Columbia, Maryland


1985-1986 Staff Nurse, Alice Peck Day Memorial Hospital, Lebanon, New Hampshire

1987-2001 Nurse Clinician/Clinical Nurse Specialist/Adult Nurse Practitioner: Thoracic Oncology,

Oncology Infusion Therapy Nurse, Dartmouth-Hitchcock Medical Center, Norris

Cotton Cancer Center, Lebanon, New Hampshire

2001-2009 Director-Advanced Practice Nursing, Department Hematology/Oncology, Dartmouth-

Hitchcock Medical Center, Lebanon, New Hampshire 2007-2009

Director-Clinical Cancer Survivorship Services, Dartmouth-Hitchcock Medical Center,

Norris Cotton Cancer Center, Lebanon, New Hampshire

Other Professional Positions

1992-1997 CALGB Newsletter, Editor of Nursing Section, National Institute of Health-Funded

Cancer and Leukemia Group B (CALGB) Oncology Nursing Committee

1992-2000 Respiratory Core Committee Nurse Liaison, National Institute of Health-Funded Cancer

and Leukemia Group B (CALGB) Oncology Nursing Committee

1997-2000 Vice-Chair, National Institute of Health-Funded Cancer and Leukemia Group B

(CALGB) Oncology Nursing Committee

2000-2011 Chair, National Institutes of Health-Funded Cancer and Leukemia Group B (CALGB)

Oncology Nursing Committee

2011-2012 Co-Chair, National Institutes of Health-Funded Alliance Oncology Nursing Committee

2012- Co-Vice Chair, National Institutes of Health-Funded Alliance Symptom

Intervention Committee

2015 - Co-Chair Hoosier Cancer Research Network Symptom Management Clinical Trial

Working Group

2017- University of Michigan Adult Palliative Medicine Executive Steering Committee

(APMESC) (Elected)

RESEARCH INTERESTS

Neuropathic Pain, Chemotherapy-Induced Peripheral Neuropathy Assessment and Treatment, Pain

Assessment

Dissertation: Smith, E. L. (2008). Clinimetric Properties of Chemotherapy-Induced Peripheral

Neuropathy (CIPN) Measurement Approaches. University of Utah College of Nursing.

GRANTS (LISTED OLDEST TO MOST RECENT)

Active

Principal Investigator

1R01CA235726-01 -- National Cancer Institute

Ellen Lavoie Smith, PhD, APRN, AOCN®, FAAN (PI)

Total Costs: $1,785,811

IDC: $557,833.23

1/1/2019 – 12/31 - 2023

Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced

Peripheral Neuropathy: A Randomized, Double-Bind, Placebo-Controlled Phase II to

Phase III Study

Co-Is: Charles Loprinzi, MD, David Zahrieh, PhD: Co-Is, Mayo Clinic, Rochester, MN

Purpose: The main objective of this Phase II-III study is test to test the efficacy of duloxetine to

prevent oxaliplatin-induced peripheral neuropathy patients with colorectal cancer.


Ellen Lavoie Smith, PhD, ANP-BC, AOCN® (PI)

University of Michigan Cancer Center Health Behavior and

Outcomes Pilot Funding

04/01/2017-2/28/2019

Total Costs: $7,186

In-Kind Support Provided by

Indiana University and Children’s

Hospital and Minnesota

Raymond Hutchinson, MD, Jamie Renbarger, MD., Laura Gilchrist, PhD, PT (Co-I)

A multi-site Pilot Study to Validate the P-CIN (Pediatric Chemotherapy-Induced Neuropathy)

Patient-Reported Outcome Measure

Purpose: To examine the reliability and validity of an electronic pediatric CIPN patient-reported

outcome measure.


Disarm Therapeutics

07/18/2019-3/31/2021

Direct Costs: $129,792.00 + 56%

Indirect Costs

A natural history study of chemotherapy-induced peripheral neuropathy-EPIPHANY

Purpose: To validate a biomarker of peripheral nerve axon damage following neurotoxic

chemotherapy in patients receiving paclitaxel or vincristine for breast cancer and lymphoma.

Co-Investigator

R01-PAR-18-559

PI: Hsiao-Lan Wang, PhD, University of Southern Florida

Ellen Lavoie Smith, PhD, MSN, RN, AOCN® , FAAN (co-I)

Submitted 2/2019

12/13/2019 – 11/30/2024

Total Costs (DC + IDC): $2,877,273

National Cancer Institute Subcontract Total Costs: $197,176

IDC: $70,781

12/13/2019 – 11/30/2024

Managing Fatigue and Pain Using Personalized Exergame Prescriptions in Head and Neck Cancer

Patients after Their Treatment

Purpose: The test a personalized exergame intervention to improve pain and fatigue following

chemotherapy/radiation treatment for head and neck cancer.

Completed

Principal Investigator

Ellen Lavoie Smith, RN, MS, OCN (PI) 1990

Master’s Thesis Completed without funding

The Role of Individualized and Tape Recorded Patient Educational Sessions on Retention of

Chemotherapy Information in Newly Diagnosed Cancer Patients

Purpose: To test the effect of tape-recorded to non-tape-recorded education on patient knowledge of

chemotherapy side effects and self-management strategies.

Ellen Lavoie Smith, MS, APRN-BC, AOCN (PI) 2004-2007

Oncology Nursing Foundation Total Costs: $44,194


Effects of a Neuropathic Pain Algorithm on Patient and Nursing Outcomes

Co-Is: Louise Meyer, MS, APRN-BC, AOCN, Marie Bakitas, MS, APRN-BC, AOCN, FAAN,

Marilyn Bookbinder, PhD, RN, Peter Homel, PhD., Camilo Fadul, MD

Purpose: To test the effect of a nurse-implemented neuropathic pain evidence-based treatment

algorithm on neuropathic pain severity, and patient function and satisfaction.

Ellen Lavoie Smith, PhD(c), MS, APRN-BC, AOCN (PI) 2006-2007

American Cancer Society Scholarship & Prouty Pilot Funds Total Costs: $66,000

Clinimetric Evaluation of Peripheral Neuropathy Measurement Approaches

Purpose: The purpose of this dissertation research was to test the sensitivity, reliability, and validity

of several measures of chemotherapy-induced peripheral neuropathy.

CTSA Pilot Project

Ellen Lavoie Smith, PhD, APRN-BC, AOCN (PI)

10/2008-10/2009

Dartmouth Center for Clinical and Translational Research Total Costs: $40,000

DMS Study: Assessing the Challenges of New Hampshire’s Cancer Survivors.

Co-Is: Allen Dietrich, MD, Tracy Onega, PhD, Kristen Anton, MS

Purpose: To describe cancer survivors’ physical, psychological, social, spiritual, and sexual function

late effects following cancer treatment.

CALGB 170601

Ellen Lavoie Smith, PhD, MS, APRN-BC, AOCN (PI)

Activation 4/15/2008

Lilly Pharmaceuticals and NCI Division of Cancer

Prevention

Total Costs: Unknown

Peer-Reviewed – R01 Equivalent

Funding via the NCI Cooperative

Group Funding Mechanisms

A Multi-site Phase III Trial of Oral Duloxetine for Treatment of Painful Chemotherapy-Induced

Peripheral Neuropathy - A CALGB National Cooperative Group Study

Co-Is: Camilo Fadul, MD, Tim Ahles, PhD, Stewart Fleishman, MD, Alice Kornblith, PhD, Charles

Shapiro, MD, Electra Paskett, PhD, Herbert Wang, PhD, Connie Cirrincione, MS

Purpose: To asses duloxetine’s effect on peripheral neuropathy-related pain and quality of life.

Ellen Lavoie Smith, PhD, ANP-BC, AOCN® (PI) 03/2013-03/2014

University of Michigan School of Nursing Total Costs: $10,000

Breast Cancer Pain (BCP) - Karen Allen Award and University of Michigan School of Nursing Pilot

Grant

Co-Is: Daniel Clauw, MD, Lynn Henry, MD, PhD, David Williams, PhD, Steven Harte, PhD, Alex

Tsodikov, PhD, Chad Brummett, MD

Purpose: The purpose of this prospective, longitudinal study was to examine whether presence of a

“pain prone” phenotype at diagnosis (prior to definitive surgery) will predict the development of

treatment-related chronic pain in 40 women with clinical stage 0-III breast cancer.


Genentech

08/-1/2014- 12/31/2016

$123,492

Addressing Quality Cancer Care: Pilot Testing the On Q Care Planning and Symptom Assessment


System

Co-I: James Yang, PhD

Purpose: The goal of this research was to test the On Q Care Planning System (CPS), a novel

computerized system for enhancing symptom assessment and management. The On Q CPS

intervention is designed to improve 1) provider adherence to evidence-based symptom assessment

and management strategies, including those captured by current cancer quality care metrics, and 2)

patient engagement in symptom assessment and management.


R03 PAR-12-039 - 1R03CA186183-01A1

04/01/2015-03/31/2017

Total Costs: $155,250

National Institutes of Health-National Cancer Institute

Co-Is: James Yang, PhD, Ingemar Merkes, MD, PhD (Co-I)

Chemotherapy-Induced Peripheral Neuropathy (CIPN) Measurement Validation

Purpose: The purpose of this mixed methods psychometric study was to examine the reliability,

validity, and sensitivity of a CIPN patient-reported outcome measure, the EORTC-CIPN20. The main

outcome of this research will be identification of a strong CIPN measurement tool for use in research

and clinical practice settings.

Co-Primary Investigator

Ellen Lavoie Smith, RN, MS, AOCN, Tim Ahles, PhD (PI) 1994

Completed without funding

Dyspnea and Quality of Life in Lung Cancer Patients – 1994

Co-I: Danette Hann, PhD

KL2 - UL1RR024986 Shanley (PI), Smith (PI for Pilot

Study)

07/01/2011-05/30/2013

University of Michigan Clinical Translational Science Award Total Costs: $60,000

Does a Pain Prone Genotype and Phenotype Predict the Development of Chronic Pain Following

Breast Cancer Treatment?

Co-Is: Daniel Clauw, MD, David Flockhart, PhD, MD, PhD, Steven Harte, PhD, Janean Holden,

PhD, RN (Mentors), Norah Lynn Henry, MD, PhD, Chad Brummett, MD (Co-Is)

Purpose: Career development objectives were to learn more about 1) pain genetics and

pharmacogenetics; 2) research designs and methodologies used in genetic and pharmacogenetic

studies; 3) pain physiology, and 4) research designs and methodologies used when exploring CNS

pain mechanisms, to include experimental pain testing methodology. A fifth career development

objective was to reinforce and expand my knowledge regarding the Responsible Conduct of

Research.

Co-Investigator

L. Herbert Maurer, MD (PI) 1992-1997

Clinical Trials in the Rural Community

Co-I: Ellen Lavoie Smith, MS, ARNP, AOCN

Purpose: To describe and address barriers to patient enrollment to cancer clinical trials in rural


settings.

# 10005385-01 Susan L. Beck PhD, APRN, FAAN (PI) 11/1/2007-10/31/2009

Oncology Nursing Foundation Total Costs: $10,845

Does Certification Make a Difference in Pain Outcomes?

Co-I: Patricia Berry PhD, APRN,BC-PCM , William Dudley PhD, Gail Towsley, PhD,

Ellen Lavoie Smith, PhD(c), MS, APRN, AOCN, Jeannine Brant, MS, CNS, AOCN (Co-I)

Purpose: To examine the influence of oncology nursing certification on pain outcomes

Co-I Role: I was the Dartmouth site PI, recruited patients, participated in data collection and analysis,

and collaborated with coauthors to disseminate of the findings.

#58299 Susan Beck, PhD, ARNP, FAAN (PI) 08/15/2006-08/14/2008

Robert Wood Johnson Grant Total Costs: $308,618

Measuring Nursing Care Quality Related to Pain Management

Co-Is: Patricia Berry PhD, APRN,BC-PCM , William Dudley PhD,

Ellen Lavoie Smith, PhD(c), MS, APRN, AOCN, Jeannine Brant, MS, CNS, AOCN

Purpose: The overall aim of this study is to develop and test a robust and parsimonious measure if the

quality of nursing care related to pain management that effectively predicts pain outcomes in

individuals with cancer in the acute-care setting

Co-I Role: I was the Dartmouth site PI, recruited patients, participated in data collection and analysis,

and collaborated with coauthors to disseminate of the findings.

Anantha Shekhar, MD (PI)

NIH Administrative Supplement 3UL 1RR025761-02S5

09/30/2009-09/29/2010


Grant to Indiana Clinical and Translational Science Institute (UL1) - Clinical and Genetic Predictors

of Vincristine-Induced Peripheral Neuropathy

Co-Is: Jamie Renbarger, MD, Ellen Lavoie Smith, PhD, APRN-BC, AOCN, Raymond Hutchinson,

MD, Patricia Robertson, MD

Purpose: To assess the psychometric properties of peripheral neuropathy measurement approaches

and the association with genetic predictors.

Co-I Role: I designed and led all aspects of the phenotyping work across four sites. I wrote the aims,

designed the methods, led multi-site training and data collection efforts, and collaborated with the

team to analyze and disseminate the findings.

Daniel Hertz, PharmD, PhD (PI) – University of Michigan 6/1/2014-5/31/15

University of Michigan School of Pharmacy Pilot Grant Total Costs: $33,860

Defining an exposure target for weekly paclitaxel infusion in breast cancer patients

Co-I: Ellen Lavoie Smith, PhD, ANP-BC, AOCN, Norah Lynn Henry, MD, Kelley Kidwell, PhD

Purpose: To demonstrate feasibility of patient enrollment and collection of pharmacokinetic and

longitudinal neuropathy data from breast cancer patients receiving weekly 1-hour paclitaxel infusions

and to assess the preliminary relationship between paclitaxel exposure and neuropathy development.

Co-I Role: I designed the CIPN phenotyping methods using in this study using the Total Neuropathy

Score and the QLQ CIPN-20. I trained and co-supervised the study staff who collected the CIPN

phenotype data, and collaborated with the team to analyze and disseminate the findings.


Lynn, N. Henry, MD, PhD (PI) – University of Michigan 6/1/2015-5/31/16 (approximate)

Damon Runyon-Lilly Clinical Investigator Award from the

Damon Runyon Cancer Research Foundation (#CI-53-10)

Total Costs: Unknown

Pilot Study of an Internet-based Self-Management Program for Symptom Control in Patients with

Early Stage Breast Cancer

Co-Is: Kelley M. Kidwell, PhD, Daniel J. Clauw, MD, Ellen M. L. Smith, PhD, APRN, AOCN,

FAAN, David A. Williams, PhD

Purpose: To determine the effect of an internet-based lifestyle and behavioral self-management

program (PROSPECT) on cancer-related symptoms. I co-designed the intervention, co-authored the

research proposal, and was involved in interpretation and dissemination of the findings.

Co-I Role: I co-designed the intervention, co-authored the research proposal, and was involved in

interpretation and dissemination of the findings.

PAR-08-248 - R01 HD062484: (R01)

Jamie Renbarger, MD – Indiana University (PI)

1/1/2011-12/31/16


NIH Child Health and Human Development Extramural Research

Pharmacogenetic Determinants of Vincristine Toxicity and Response

Co-Is: Ellen Lavoie Smith, PhD, ANP-BC, AOCN (UM PI), Raymond Hutchinson, MD,

Patricia Robertson, MD (Co-Is)

Purpose: To determine whether candidate gene polymorphisms or other less obvious genetic variants

identified using a genome wide approach are predictive of vincristine neurotoxicity.

Co-I Role: I served in a co-PI capacity for the overall grant and the UM site PI. I co-wrote the grant

and designed and led all aspects of the study related to the vincristine neuropathy measurement aims,

methods, analysis, and dissemination. I was involved in interpretation and dissemination of the

pharmacogenetic findings.

Janean Holden (PI)

University of Michigan MICHR translational research grant

3/2017 – 12/2017


Alpha-adrenergic Modulation of Oxaliplatin-Induced Hyperalgesia.

Purpose: To obtain preliminary data regarding the potential effect of Prazocin +/- Duloxetine for the

treatment of oxaliplatin-induced peripheral neuropathy.

Co-Is: Ellen Lavoie Smith & Robert Ploutz-Snyder

Co-I Role: My role was to co-conceptualize the aims, provide consultation regarding oxaliplatin and

duloxetine dosage/route and administration schedule to maximize potential translation of the findings

to human, interpret toxicity patterns, and contribute to the analysis and interpretation of the findings.

The findings served as preliminary data for a submitted R01 (currently under review).

Consultant

1 RC1 CA146882-01: FOA 0D09-003

Jamie Renbarger, MD (PI)

09/30/2009-09/29/2011

Total = $82,681 - 24 months

NIH Challenge in Health & Science Research Recovery Act Limited Competition: NIH Challenge in

Health & Science Research – Developing a Prediction Model for Vincristine-Induced Peripheral

Neuropathy

Co-Is: Ellen Lavoie Smith, PhD, APRN-BC, AOCN (Consultant), Raymond Hutchinson, MD,


Patricia Robertson, MD

Purpose: To develop a prediction model to guide Vincristine dosing based on clinical and genetic

variables.

Consultant Role: I assisted with the interpretation of the neuropathy phenotype data for inclusion in

the prediction model.

Active Training Grants

Ellen Lavoie Smith, PhD, APRN, AOCN®, FAAN (Sponsor)

American Cancer Society Training Grant

7/1/2017-6/30/2019


Trainee—Grace Kanzawa-Lee

Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy: A Pilot RCT

Purpose: The purpose of this pilot dissertation study is to examine the effect of a home-based walking

program on chemotherapy-induced peripheral neuropathy severity and outcomes.

Faculty Role: I currently serve as the Faculty PI for this study.

Ellen Lavoie Smith, PhD, ANP-BC, AOCN® (PI) 4/15/2015 -7/31/2018

Robert Wood Johnson Total Costs: $150,000

The purpose of this grant is to fund two predoctoral students enrolled in our PhD Program.





Jonas Center for Nursing and Veterans Healthcare $30,000

The purpose of this grant is to provide three scholarships to predoctoral students (2 PhD, 1 DNP)

enrolled in our doctoral programs.


Jonas Center for Nursing and Veterans Healthcare $20,000

Co-I: Lisa Kane-Low, PhD, CNM

The purpose of this grant is to provide two scholarships to predoctoral students (1 PhD, 1 DNP)

enrolled in our doctoral programs.

Completed Training Grants

Ellen Lavoie Smith, PhD, ANP-BC, AOCN (UM Site PI)

BCOG Center for Bio Behavioral Oncology Research and

Training Pilot Grant

7/1/2014-6/30/15


Co-Is: Victoria Champion, PhD, RN, Charles Given, PhD, Barbara Given, PhD, RN, David

Haggstrom, MD

Purpose: The mission of the BCOG Center for Bio Behavioral Oncology Research and Training is to

foster a collaborative, interdisciplinary and interuniversity community of researchers, whose goal is

to decrease the burden of cancer through innovative bio /behavioral research, training of our future


researchers, and translation of science to the population.

Co-I Role: I served as the UM site PI for this training grant.

Pending Grant Submissions

Primary Investigator

None pending

Unfunded Grants

Primary Investigator

Ellen Lavoie Smith, PhD, APRN-BC, AOCN (PI) 05/2008-06/2009

NH Department of Health and Human Services $132,000 Awarded

DMS Study: Assessing and Monitoring the Challenges of

Cancer Survivorship and Expanding Capacity for and Access to

Survivorship Services and Palliative Care

Funds rescinded due to budget cuts

Co-Is: Ira Byock, MD, Tracy Onega, PhD, Kristen Anton, MS

Purpose: To describe cancer survivors’ physical, psychological, social, spiritual, and sexual function

late effects over time in patients receiving survivorship and palliative care services.

Amendment to CALGB 170601

Ellen Lavoie Smith, PhD, APRN, AOCN® (PI)

Submission 06/2011, not funded

CALGB Foundation Total Costs: $119,325

CALGB Symptom Intervention Pilot Funds: Pharmacogenetic Predictors of Duloxetine Efficacy

when Used to Treat Painful Chemotherapy-Induced Peripheral Neuropathy

Co-Is: Jamie Renbarger, MD, MS, Todd Skaar, PhD, Debra Barton, PhD, RN, AOCN, FAAN,

Deanna L. Kroetz, PhD, Herbert Pang, PhD, Lydia Hodgson, MS

Purpose: The aim of this exploratory pilot study was to identify associations between duloxetine

response and variability in genes involved in pharmacokinetic and pharmacodynamic pathways and

the neuropathic pain pathway when duloxetine is used to treat taxane or platinum-induced CIPN pain.

R01 PA-10-006


Resubmission 03/05/2011

Not funded

NIH National Cancer Institute Total Costs: $2,775,868

NIH Mechanisms, Models, Measurement, & Management in Pain Research (R01): Central Nervous

System Mechanisms of Painful Chemotherapy-Induced Peripheral Neuropathy

Co-Is: Daniel Clauw, MD, David Williams, PhD, Steven Harte, PhD, Alex Tsodikov, PhD,

Janean Holden, PhD, RN

Purpose: To examine whether presence of a “pain prone” phenotype at diagnosis (prior to definitive

surgery) will predict the development of treatment-related chronic CIPN pain in women with breast

cancer who received neurotoxic chemotherapy.

First Submission: Impact/Priority Score = 47; Percentile 33; Second Submission: Impact/Priority

Score = 39; Percentile 34

Imbedded Pilot RFA-NR-12-006


Submission Date 05/16/2012

NIH, National Institute of Nursing Research Not funded


Centers of Excellence in Symptom Science (P30) Pilot Project - Predicting Chronic Neuropathy Pain

in Patients with Multiple Myeloma

Co-Is: Christopher Friese, PhD, RN, AOCN®, Daniel Lebovic

Purpose: To provide preliminary evidence of the presence of a pain prone phenotype, and whether

pain proneness will predict the development of chronic chemotherapy-induced peripheral neuropathy

pain and other somatic symptoms in 40 patients with multiple myeloma receiving neurotoxic

chemotherapy.

Ellen Lavoie Smith, PhD, APRN, AOCN® (PI) Submission Date 01/20/2013

International Association for the Study of Pain (IASP)

Foundation

$20,000

Not funded

IASP Early Career Grant

Co-Is: Daniel Clauw, MD, Lynn Henry, MD, PhD, David Williams, PhD, Steven Harte, PhD,

Alex Tsodikov, PhD, Chad Brummett, MD


surgery) will predict the development of treatment-related chronic pain in 40 women with clinical

stage 0-III breast cancer. Received score of 2.7 on 1-5 Scale (1= excellent 2=good, 3=average, 4=fair,

5=poor).

R01 PA-10-006


First Submission 2/2015

Resubmission 10/2016

Resubmission 6/2017-triaged

NIH National Cancer Institute Total Estimated Costs: $1,928,549.00

NIH Mechanisms, Models, Measurement, & Management in Pain Research (R01): A Placebo-

Controlled RCT Testing a Targeted Multimodal Intervention for Chemotherapy-Induced Peripheral

Neuropathy Pain—the MICH-NP study.

Co-Is: David Williams, PhD, James Yang, PhD

Purpose: To test with duloxetine plus PROSPECT – a self-guided on-line cognitive behavioral

management program—would work better to control painful CIPN than duloxetine alone in patients

with low emotional functioning and receiving oxaliplatin chemotherapy.

First submission - Impact 36 and 25th percentile, Impact 42 and 38th percentile following

resubmission, 3rd submission was triaged.

R21 PA-16-052

Srisuda Ngamkham, PhD, RN (PI)


First Submission 12/2017

7/1/2018 – 6/30/2020

4/3/18 Review - Triaged

Fogarty International Center Total Costs: $342,379 (IDC

$82,160)

Non-pharmacology Pain Management in Pain Research: Thai Buddhism-based Mindfulness for Pain

Management in Thai Outpatients with Cancer: A Preliminary Study

Co-Is: James Yang, PhD

A RCT trial assessing the effect of a mindfulness meditation and education intervention to control

worse pain in individuals with cancer.

Purpose: To test the effect of a Buddhism-based mindfulness intervention for cancer pain.





OSure – University of Michigan Pilot Grant


Leah Robinson, PhD (PI)

First Submission 2/1/2018

2nd Submission 4/6/2018

University of Michigan Cancer Center Total Costs: $75,000

Pilot Testing a Movement Intervention for Pediatric Cancer Survivors with Vincristine-Induced

Peripheral Neuropathy

Co-Is: Raymond Hutchinson, MD, Jamie Renbarger, MD, MS

Purpose: The main objective of this pilot study is to describe the incidence, severity, and temporal

patterns of vincristine-induced peripheral neuropathy (VIPN) (e.g., numbness, tingling, and pain in

upper and lower extremities) and associated mobility impairments experienced ≥ one year following

vincristine treatment, and develop and pilot test a movement-based intervention that could ameliorate

vincristine-associated late effects.

Co- Investigator

1 P50 CA244684-01

PI: Friese (contact), Titler, Hawley

Ellen Lavoie Smith, PhD, APRN, AOCN® (co-I/pilot project

PI)

Submitted 2/2019

Total Budget: 9.2 Million

Scored but not funded

National Cancer Institute - Michigan Implementation Science

Center in Cancer Control to Improve Symptom Management

(Michigan IS-C3)

A Pilot Study of NP-rECCovER—An Implementation Strategy to Improve Adoption of Non-Opioid

Treatment in Patients with Cancer-related Neuropathic Pain

Purpose: To describe the feasibility, usability, sustainability, and patient/provider satisfaction

associated with use of NP-rECCovER—a new implementation intervention to improve adoption of

evidence-based neuropathic pain treatment guidelines in patients with cancer.

R01 PA-10-006 Lynn Henry, MD, PhD

NIH National Cancer Institute

Submission Date 02/05/2012

Resubmission 11/05/2012

Not funded

NIH Mechanisms, Models, Measurement, & Management

in Pain Research (R01): Does a pain prone phenotype

predict chronic pain post breast cancer treatment?


Co-Is: Ellen Lavoie Smith, PhD, APRN, AOCN, Daniel Clauw, MD, David Williams, PhD, Steven

Harte, PhD, Alex Tsodikov, PhD, Chad Brummett, MD


surgery) will predict the development of treatment-related chronic pain in 200 women with clinical

stage 0-III breast cancer.

Impact Score 45, Percentile 36

(R01) PA-10-006 Lynn Henry, MD, PhD (PI) Submission Date 02/05/2012


NIH National Cancer Institute, NIH Mechanisms, Models,

Measurement, & Management in Pain Research

First submission scored but not

resubmitted

Chronic Pain in Breast Cancer Survivors: A Mechanism-Based Approach

Co-Is: Ellen Lavoie Smith, PhD, APRN, AOCN, Daniel Clauw, MD, David Williams, PhD,

Steven Harte, PhD, Alex Tsodikov, PhD

Purpose: The overall objective of this research is to determine the differential effects of centrally- and

peripherally-acting analgesics on the best experimental measures of centralized pain: experimental

pain testing and functional neuroimaging. Our ultimate goal was to obtain scientific evidence driving

future research investigating the efficacy of CNS-targeted, individualized pharmacologic and non-

pharmacologic approaches to CIPN pain prevention and treatment.

R01 PA-10-006 Lynn Henry, MD, PhD (PI) Submission Date 10/5/2012

NIH National Cancer Institute Not Scored

NIH Mechanisms, Models, Measurement, & Management in Pain Research (R01): Does a pain prone

phenotype predict response to duloxetine treatment?

Co-Is: Ellen Lavoie Smith, PhD, APRN, AOCN®, Daniel Clauw, MD, David Williams, PhD,

Steven Harte, PhD, Alex Tsodikov, PhD, Chad Brummett, MD (Co-Is)

Purpose: To examine whether presence of a “pain prone” phenotype predicts response to a centrally-

acting agent, duloxetine, as a treatment for chronic pain.

Daniel Hertz (PI)

PA-16-029: Applying Metabolomics to Drive Biomarker

Discovery in Symptom Science (R21)

7/1/2017 – 6/30/2019

Total Costs: $426,250.00

Not Discussed

Metabolomic Profiles Associated with Paclitaxel-Induced Peripheral Neuropathy.

Co-Is: Ellen Lavoie Smith & Kathleen A. Stringer

Purpose: To Identify pre- and post-treatment metabolomic profiles that are associated with paclitaxel-

induced peripheral neuropathy sensitivity

Ellen Lavoie Smith, PhD, APRN, AOCN®, FAAN (Co-PI)

Janean E Holden, PhD, RN, FAAN (Co-PI)

First Submission 5/1/2018

Withdrawn due to lack of cost-share

agreement

The University of Michigan Health System – Peking

University Health Science Center

Joint Institute for Translational and Clinical Research


9/1/2018 – 8/31/2020

Chemotherapy-Induced Peripheral Neuropathy (CIPN) Measurement Validation in China

Co-Is: Shaomei Shang, PhD, RN & Dr. Zhiwen Wang, PhD, RN of the Peking University School of

Nursing

Purpose: The main objective of this psychometric study is to test the Chinese version of the EORTC-

QLQ CIPN20 patient-reported outcome measure for CIPN.

Training Grants F31-PA-18-671

Ellen Lavoie Smith, PhD, APRN, AOCN® (PI) First Submission 8/7/18

Scored at 24th percentile, not funded


Clare Donohoe-Pre-Doctoral Candidate nor resubitted

National Cancer Institute - Ruth L. Kirschstein National

Research Service Award (NRSA)

Individual Predoctoral Fellowship (Parent F31)

Total Costs: $116,747.00

Combating the Opioid Epidemic: Can Understanding the Clinical

Phenotype of Adolescents and Young Adults with Sickle Cell Pain Inform Future Non-

Pharmacologic Interventions?

Purpose: The purpose of this longitudinal study is to describe the phenotypic characteristics (i.e.,

physiologic, psychologic, and situational) of adolescents and young adults (14-30) with SCD and

identify which characteristics are predictive of pain severity, pain interference, and increased opioid

consumption within 6 months of baseline phenotyping.

HONORS AND AWARDS

1990 Dartmouth-Hitchcock Medical Center, Student Assistantship in Cancer

Research Award

2004-2008 American Cancer Society - $60,000, Doctoral Scholarship Award

2005 Nursing Spectrum – New England Division, Nursing Excellence Award for Advancing

the Profession

2006 Dartmouth Hitchcock Medical Center, Madelyn R. Smith Promise Award in Nursing

2010 University of Michigan School of Nursing, Visiting Scholar (July and August)

2011 American Academy of Collegiate Nursing, Novice Educator Award Nomination –

Award not received

2012 University of Michigan School of Nursing, Karin Allen Award

2013 University of Michigan School of Nursing, Teacher of the Year

2013 Oncology Nursing Society, New Investigator Award

2014 Midwestern Nursing Research Society, Harriet Werley New Investigator Award

2015 ONS Excellence in Writing Award for Quantitative Nursing Research

2015 & 2018 University of Michigan Honors Student/Mentor Research Award

2018 Fellows of the National Institute of Nursing Research Welch/Woerner Path Paver

Award

MEMBERSHIPS IN PROFESSIONAL SOCIETIES

1984-present Oncology Nursing Society

1991 International Lung Cancer Society

1991 Sigma Theta Tau - International Nursing Honor Society

2006-present Advanced Nursing Research Special Interest Group , Oncology Nursing Society

2010-present American Society of Clinical Oncology

2010-present International Association for the Study of Pain

2011-present Midwest Nursing Research Society

2012-present Pharmacogenomics Research Network (PGRN)

2012-2015 Behavioral Cancer Oncology Group (BCOG)

2015-present American Nurses Association

2016-present Fellow in the American Academy of Nursing

2018-present Peripheral Nerve Society Toxic Neuropathy Special Interest Group

EDITORIAL POSITIONS, BOARDS, AND PEER-REVIEW SERVICE


1992-1997

1992-1999

Cancer and Leukemia Group B (CALGB) Oncology Nursing Committee Newsletter,

Nursing Section; Editor

ONS Nursing Scan in Oncology; Abstractor

2010-present Journal of Cancer Education

2010-present Journal of Pain and Symptom Management

2011-present Breast Cancer Research and Treatment

2011-present European Journal of Oncology Nursing

2013-present Supportive Care Cancer

2013-present Clinical Journal of Oncology Nursing

2013-present European Journal of Cancer Care

2014-present Cancer Nursing

2014-present Oncology Nursing Forum

2017-present Journal of Clinical Oncology

2017-present Cancer

2012-2014 University of Michigan Comprehensive Cancer Center – Protocol Review Committee

2013-2016 Oncology Nursing Society Career Development & Dissertation Award Grant Reviewer

2015-2016 NIH/CSR Cancer Diagnostics and Treatments (CDT) SBIR Study Section

2016-2018 NIH/NCI Provocative Questions Study Section

2016 External Advisory Committee; Michigan Institute for Clinical and Health Research

(MICHR) University of Michigan

2016 National Cancer Institute – Division of Cancer Prevention Clinical Trials Planning

Meeting Participant

2017 The Consortium on Clinical Endpoints and Procedures for Peripheral Neuropathy

Trials (CONCEPPT) of the Analgesic, Anesthetic, and Addiction Clinical Trial

Translations, Innovations, Opportunities and Networks (ACTTION) – Participant and

Presenter

2016-2018 Rackham Doctoral Fellowship Review Committee

2018-present American Society of Clinical Oncology (ASCO) Clinical Guidelines Committee

2018-present University of Michigan Health Sciences and Behavioral Sciences (HSBS) Institutional

Review Board

2018-2019 Oncology Nursing Society Research Priorities Task Force

2019 NIH HEAL Study Section

2019-present FNIR Awards Committee

2020 NIH Nursing and Related Clinical Sciences (NRCS) Study Section

2020 NIH Small Business: Cancer Diagnostics and Treatments (CDT) Study Section (Mail

Reviewer)

TEACHING

Teaching: Advising or Other Formal Role for Undergraduate, Master’s, PhD, DNP, Post-

Doctoral Fellows, or Certificate Projects

Trainee Name Time period

Degree

program

Role:

Title of Project

Terri Voepel-Lewis 2010 Fall PhD-Nursing Academic Advisor

Celia Bridges 2012-2013 PhD-Nursing Academic Advisor

Maureen Berlucchi 2010-Fall MSN, ACNP Academic Advisor


Andrea Engles 2011 Winter MSN, ACNP Academic Advisor

Sasha Murphy 2011 Winter MSN, ACNP Academic Advisor

Kathryn Kovanda 2011 Fall MSN, ACNP Academic Advisor

Kasandra Risch 2011 Fall MSN, ACNP Academic Advisor

Pam Stewart 2011 Fall MSN, ACNP Academic Advisor

Amber Peck 2011 Fall MSN, ACNP Academic Advisor

Kari Durbin 2012 Fall MSN, ACNP Academic Advisor

Stephanie Peterman 2012 Fall MSN, ACNP Academic Advisor

Stephanie Soulia 2012 Fall DNP Academic Advisor

Deborah Thornton 2009-2011 BSN Honor Student Primary Mentor

Karin Thomas 2012-2014 BSN Honors Student Primary Mentor

Kelsey Kippe 2014-2016 BSN Honors Student Primary Mentor

Rylie Haupt 2015-2017 BSN Honors Student Primary Mentor

Zachary Chornoby 2016-2018 BSN Honors Student Co-Primary Mentor

Jenna Swets 2016-2019 BSN Honors Student Primary Mentor

MiJung Jung 2009-2010 MSN-ACNP NURS 699-Reader

Terese Cook 2009-2010 MSN-ACNP NURS 699-Reader

Caralee Smith 2010-2011 MSN-ACNP NURS 699-Advisor

Jesse Moes 2010-2011 PhD-Nursing NURS 699-Reader

Kathryn Evans 2010-2011 MSN-ACNP NURS 699-Reader

Sarah Taylor 2010-2011 MSN-ACNP NURS 699-Reader

Joyce Nancarrow 2011-2012 MSN NURS 699-Reader

Monica Wagner 2012-2013 PhD-Nursing NURS 699-Reader

James Kelly 2012-2013 BS-Pre-Med UROP Sponsor

Malavika Sengupta 2012-2013 Neuroscience UROP Sponsor

Anna Berezovsky 2012-2013 LS & A- Honors UROP Sponsor

Monica Wagner 2013 Spring PhD NURS 797-Independent Study (3 credits)

Celia Bridges 2013 Summer PhD NURS 797-Indepencent Study (2 credit)

Jesse Moes 2010-2012 PhD - Nursing Dissertation Committee Member

Dusty Filliung 2010-2013 PhD - Nursing Dissertation Committee Member

Monica Wagner 2012-2018 PhD-Nursing Dissertation Committee Member

Deborah Lee 2016-20XX PhD-Nursing Michigan State University – Dissertation

Committee Member and Consultant

Noah Zanville 2015-2018 PhD-Nursing Indiana University – F31 Consultant and

Informal Mentor

Terri Voepel-Lewis 2011-2014 PhD-Nursing Dissertation Committee Co-Chair

Robert Knoerl 2013- 2017 BSN-PhD

Hillman Scholar

Dissertation Committee Chair

Grace Kanzawa 2013-20XX BSN-PhD

BSN Honors

Student

Hillman Scholar


Clare Donohue 2015-20XX BSN-PhD

Hillman and T32

Scholar



Katelyn Webster 2018-20XX BSN-PhD T32

Scholar

Dissertation Committee Member

Youmin Cho 2019-20XX PhD Pre-

candidate


Rima Saad 2019-20XX PhD Candidate

American

University of

Beirut

Dissertation Committee Member

Stephanie Soulia 2012 -2018 DNP Project Chair

Nusara Prasertsri, PhD 2015-2016 Post-Doctoral

Fellow

D43 Training Grant Post-Doctoral Fellow

Research Advisor

Srisuda Ngamkham,

PhD

2017 - 2018 Post-Doctoral

Fellow

D43 Training Grant Post-Doctoral Fellow

Research Advisor

Elizabeth Duffy, DNP 2016-present Assistant

Clinical

Professor

Faculty Mentor

Lenette Jones, PhD 2017-2018 Assistant

Professor

Faculty Mentor

Laura Saslow, PhD 2017-2018 Assistant

Professor

Advocate – 3rd Year Review

University of Michigan School of Nursing Teaching Activities

Time period Degree program

Role:

Title of Project

2009-Fall

Term

BSN NURS 357 (2)-Introduction to the Research Approach in

Nursing

2009-Winter

Term

BSN NURS 258 (2)-Assessing the Experience of Health and

Illness-Seminar Faculty-BSN Sophomores

2009-Winter

Term

MSN-ACNP NURS 506-Oncology Clinical Lecture

2009-2011 Fall

Terms

MSN-ACNP NURS 502-Oncology Pathophysiology Lecture

2010-Fall

Term

BSN NURS 495-Smith Program of Research Lecture

2010-Fall

Term

BSN NURS 254-Pain Management Lecture

2010-Fall

Term


Nursing (61 Students)

2010-Fall

Term

MSN-ACNP NURS 532-Pain Theory Lecture

2011-Winter

Term



2011-Fall PhD NURS 869-Smith Program of Research Lecture

2012 Fall

2013 Winter

2014 Winter

Second Career NURS 536-Guest Lecture-CALGB 170601-A Randomized

Controlled Trial


2015 Winter

2012, 2013

Winter Term



2013 Fall BSN NURS 245-Pathophysiology-Co-faculty

2013 Fall

2014 Fall

Undergrads& graduate

students from multiple

disciplines

NURS 502-Cancer Course-Pain Lecture – Recorded Lecture

2013 & 2014

Fall

PhD NURS 869-Theoretical Underpinnings Guiding My Program

of Research Lecture

2014 Winter BSN NURS 395-(2)-Honors Seminar

2014 Winter BSN NURS 257 (3)-Introduction to the Research Approach in

Nursing (144 students)

2014 Fall BSN NURS 245-Pathophysiology- Co-faculty

2015 Winter BSN NURS 395-Honors Seminar

2015 Winter BSN NURS 257 (3)-Introduction to the Research Approach in

Nursing (164 students)

2016 Winter BSN NURS 395 (2)-Honors Seminar

2015-2018 Fall PhD NURS 890 (3)-Substantive Research Focus I

2016-2019

Winter

PhD NURS 891 (3)-Substantive Research Focus II

Outside the University of Michigan

Dartmouth Medical School

Time period Role

2008-July Cancer Survivorship Component of Hematology/Oncology DMS Elective for 4th Year

Medical Students

Dartmouth-Hitchcock Medical Center

Time period Role

1982-present Numerous lectures to health-care professionals (see invited presentations)

1982-present Informal clinical teaching to medical students, housestaff, and nursing students

Regional

Time period Role

2006 Preceptor High School Honors Student-Dartmouth Research Practicum

2006-Fall Adjunct Professor Colby-Sawyer College-Medical Surgical Nursing Course

1991 Nurse Preceptor for Undergraduate and Graduate Students: University of New

Hampshire, Norwich University, University of Vermont, MGH Institute of Health

Professions

COMMITTEE, ORGANIZATIONAL, AND VOLUNTEER SERVICE

Institutional

1989 Dartmouth-Hitchcock Medical Center, Safe Handling Task Force, Committee Member

1989-2009 Dartmouth-Hitchcock Medical Center, Oncology Chemotherapy/Mini-Course

Curriculum Planning Committee, Committee Member


1992 Dartmouth-Hitchcock Medical Center, Thoracic Oncology Strategic Planning

Committee, Committee Member

1992 Dartmouth-Hitchcock Medical Center, Survivorship Committee, Committee Member

1992-1995 Dartmouth-Hitchcock Medical Center, Great American Smoke Out - American Cancer

Society, Chair

1992-2000 Dartmouth-Hitchcock Medical Center, Oncology Patient Education Committee, Chair

1994-1995 Dartmouth-Hitchcock Medical Center, Cancer Clinical Review Committee, Committee

Member

1995-2000 Dartmouth-Hitchcock Medical Center, Patient Resource Center Committee, Committee

Member and Chair

1999-2000 Dartmouth-Hitchcock Medical Center, Mid-Level Provider Task Force, Committee

Member

2006 Dartmouth-Hitchcock Medical Center, Chair Inpatient Service Consultation Quality

Improvement Group, Committee Member

2006 Dartmouth-Hitchcock Medical Center, Survivorship Clinic Planning Committee, Chair

2006 Dartmouth-Hitchcock Medical Center, APN RVU Subcommittee, Chair

2008 Dartmouth-Hitchcock Medical Center, Getting to Yes – Inpatient Access Committee,

Committee Member

2008 Dartmouth-Hitchcock Medical Center, Nursing Research Taskforce, Committee Member

2009, 2010 University of Michigan School of Nursing, MNRS Student Abstract Submissions

Reviewer, Abstract Reviewer

2009, 2010, University of Michigan School of Nursing, Dean’s Research Day, Abstract Reviewer

2013

2009-2012 University of Michigan Health Systems/School of Nursing, UMHS/SON Nurse Research

Partner Committee, Member & Abstract Review Chair

2009-present University of Michigan School of Nursing, Cancer Center Member, Member

2010 University of Michigan School of Nursing, Faculty Development Task Force, Member

2010-2011 University of Michigan School of Nursing, LEO Major Review Committee, Member

2010-2011 University of Michigan School of Nursing, Committee on Academic Admissions and

Scholarly Standing (CAASS), Member

2011 University of Michigan – Provost-Invited, Classroom Technology Focus Group, Member

2011 Visiting Students & Faculty: Chiba University, Japan, International

Collaboration/Advisement, Consultant/Host

2011-2012 University of Michigan School of Nursing, Technology Advisory Committee, Member

2011-2013 University of Michigan School of Nursing – Division 1, Social Committee, Member

2011-2013 University of Michigan School of Nursing, DNP Advisory Committee, Member

2011-present University of Michigan School of Nursing, New Building: Research & Classroom

Subcommittees, Member

2012-2013 University of Michigan School of Nursing, Dean’s Research Day Planning Committee,

Vice-Chair

2012-2015 University of Michigan Cancer Center, Protocol Review Committee – Cancer Center,

Member


Chair

2013-2014 University of Michigan Health System, Clinical Trials Workflow Committee, Member

2013-2014 University of Michigan Health System, Pain and Comfort Committee, Member


2013-2014 University of Michigan School of Nursing, Division I Advisory Committee, Member

2013-2014 University of Michigan School of Nursing, Teaching/Learning Technology Task Force,

Member


Chair

2014-2017 University of Michigan Faculty Senate Member

2014-2015 University of Michigan Department 1 Faculty Search Committee Chair

2015-2017 CAASS Ex-Officio Member

2015-2017 Curriculum Committee Ex-Officio Member

2016-2017 University of Michigan Department Oncology Faculty Search Committee Member

2018-2020 University of Michigan Palliative Care Steering Committee

2019 Productivity Task Force: University of Michigan School of Nursing

2020 Civility and Student Evaluations Task Force: University of Michigan School of Nursing

Regional

2007-2009 State of New Hampshire Department of Health and Human Services, Cancer

Survivorship Subcommittee, Committee Member

National

1991-2000 National Cancer Institute, Patient Education Committee, Member

1992-2000 National Institute of Health-Funded Cancer and Leukemia Group B (CALGB) Oncology

Nursing Committee, Respiratory Core Committee Nurse Liaison

1997-2000 National Institute of Health-Funded Cancer and Leukemia Group B (CALGB) Oncology

Nursing Committee, Vice-Chair

2000-2011 National Institutes of Health-Funded Cancer and Leukemia Group B (CALGB) Oncology

Nursing Committee, Chair

2003-2004 Oncology Nursing Society, Evidence Based Practice Subgroup of the Research Advisory

Committee, Member

2003 Oncology Nursing Society, Research Advisory Panel: Evidence-Based Practice

Subgroup, Committee Member

2006 Oncology Nursing Society, Cooperative Group Nursing Research Training Program,

Curriculum Planning Committee-Program Moderator

2008 National Institute of Health, State of the Science Committee Focused on Chemotherapy-

Induced Peripheral Neuropathy, Member

2011 National Institute of Health – National Cancer Institute Symptom Management and

Quality of Life Steering Committee, Chemotherapy-Induced Peripheral Neuropathy

Working Group, Member

2011-2012 National Institutes of Health-Funded Alliance Oncology Nursing Committee, Co-Chair

2012 National Institute of Health – National Cancer Institute Symptom Management and

Quality of Life Steering Committee, Symptom Management and Quality of Life Steering

Committee (SxQOL SC), Ad Hoc, Reviewer

2012- National Institutes of Health-Funded Alliance Symptom Intervention Committee, Co-

Vice Chair

2013 Oncology Nursing Society, Chemotherapy-Induced Peripheral Neuropathy Survey

Project Team, Chair


2013 American Society of Clinical Oncology, Neuropathy in Cancer Patients Clinical

Guideline Committee, Member

2013 National Institutes of Health-Funded Alliance Symptom Intervention Committee,

Chemotherapy-Induced Peripheral Neuropathy Working Group, Member

2018-2022 American Society of Clinical Oncology (ASCO) Survivorship Guideline Advisory Group

2019-present Disarm Therapeutics Advisory Board

2019-present Peripheral Nerve Society Toxic Neuropathy Board of Directors

International

2014-2015 MichiKen Teaching and Service Trip – Meru, Kenya, Africa: Consulted with nurse and

physician leaders at Consolata Hospital regarding approaches to enhance translation of

research evidence into practice and the provision of oncology services to rural Kenyans

CONSULTING POSITIONS

2002 Advisor/Consultant, Lilly Pharmaceuticals

2005 Advisor/Consultant, Bristol-Myers Squibb

2011 Advisor/Consultant, Millennium Pharmaceuticals

2013-2014 On Q Health Consultant

2014-2015 Consolata Hospital, Meru, Kenya, Africa

2016 El Camino Hospital Cancer Center, Mountain View, CA – CIPN Assessment QI Project

2017 American Society of Clinical Oncology (ASCO): Grant Writing

2017 Mundipharma Research, Cambridge, England

2018 Windrose Consultant Group, London, England

2018 Diana Martinez, MD, Columbia University, New York, NY

2018-present University of Southern Florida

2018-present Disarm Pharmaceuticals

2018-present Asahi Kasei Pharma Corporation

VISITING PROFESSORSHIPS, SEMINARS, AND EXTRAMURAL INVITED

PRESENTATIONS

Regional Invited Presentations

1983 Autologous Bone Marrow Transplantation: Constipation Management - Nursing Grand

Rounds, Dartmouth-Hitchcock Medical Center, Hanover, NH

1987 Breast Cancer Chemotherapy, Dartmouth-Hitchcock Medical Center, Hanover, NH

1988-1999 Biannually, Nursing Care of the Patient Receiving Cancer Chemotherapy, Dartmouth-

Hitchcock Medical Center, Lebanon, NH

1990-2002 Biannually, Oncology Core Class: Lung Cancer: Diagnosis, Treatment, and A Case

Approach to Related Oncologic Emergencies, Dartmouth-Hitchcock Medical Center,

Lebanon, NH

05/1991 Nursing Care of the Patient Receiving Cancer Chemotherapy, Saint Anselem's College,

Manchester, NH

05/1991 Lung Cancer Educational Series, Dartmouth-Hitchcock Medical Center, Lebanon, NH

05/1991 Lung Cancer Educational Series: Public Lectures. Dartmouth-Hitchcock Medical

Center, Lebanon, NH

05/1991 Cancer Patient Education: Nursing Grand Rounds, Dartmouth-Hitchcock Medical

Center, Lebanon, NH


03/1992 Dyspnea and Quality of Life, Veterans Administration Hospital,

White River Junction, VT

11/1992 Clinical Trials in the Rural Community: The Nursing Role, Dartmouth-Hitchcock

Medical Center, Lebanon, NH

05/1997 Chemotherapy Highlights for Primary Care Providers, Dartmouth-Hitchcock Medical

Center, Lebanon, NH

10/1997 Clinical Trials in Rural Populations: Nurse Executive Meeting, Dartmouth-Hitchcock

Medical Center, Lebanon, NH

11/1997 Dyspnea and Quality of Life of Patients with Lung Cancer: Irene Bradley Parker

Conference, Dartmouth-Hitchcock Medical Center, Lebanon, NH

11/1997 Dyspnea and Quality of Life of Patients with Lung Cancer/Dyspnea Management for

Nurses, Oncology Nursing Society Chapter, Lebanon, NH

1998 What Visiting Nurses Need to Know about Chemotherapy Side Effects, Visiting Nurse

Association, West Lebanon, NH

07/1999 How to Place Patients on Clinical Trials Role Play, Dartmouth-Hitchcock Medical

Center, Lebanon, NH

08/1999, Sleep Disturbances - Prostate Cancer Support Group, Dartmouth-Hitchcock Medical

Center, Lebanon, NH

09/1999 Oncology for Community Nurses, Vermont Technical College, Montpelier, VT

10/1999 Oncology Jeopardy for Outreach Oncology Nurses, Dartmouth-Hitchcock Medical

Center, Lebanon, NH

1999-2003 Biannually, Chemotherapy Jeopardy, Dartmouth-Hitchcock Medical Center,

Lebanon, NH

03/2000 Lung Cancer: Diagnosis, Treatment, and Symptom Management, Oncology Nursing

Society Chapter, Dover, NH

03/2000 Sleep Disturbances – Brain Tumor Support Group, Dartmouth-Hitchcock Medical

Center, Lebanon, NH

09/2002, Oncology Core Class: Metabolic Emergencies, Dartmouth-Hitchcock Medical

2003, 2004 Center, Lebanon, NH

09/2003 Glutamine for the Treatment of Peripheral Neuropathy, Advanced Practice

Nursing Retreat, Portsmouth, NH

08/2005 Assessment and Treatment of Neuropathic Pain, New Hampshire Nurses Association,

Portsmouth, NH

11/15/2006 Great Issues in Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH

06/01/2007 A Decade of Interdisciplinary Collaboration to Understand, Measure, and Treat

Chemotherapy-Induced Peripheral Neuropathy (CIPN) – Hematology/Oncology- Norris

Cotton Cancer Center Ground Rounds, Dartmouth-Hitchcock Medical Center,

Lebanon, NH

10/2007 Malignancy-Related Peripheral Neuropathy - Hematology/Oncology Mini-Course,

Dartmouth-Hitchcock Medical Center, Lebanon, NH

10/2007 Superior Vena Cava Syndrome Hematology/Oncology Mini-Course,

Dartmouth-Hitchcock Medical Center, Lebanon, NH

10/12/2007 Peripheral Neuropathy Measurement Approaches, North Eastern Clinical Oncology

Society, Burlington, VT

02/15/2008 Clinimetric Properties of Chemotherapy-Induced Peripheral Neuropathy (CIPN)


Measurement Approaches: 22nd Annual Neuroscience Day, Dartmouth College,

Hanover, NH

03/15/2008 Developing a Cancer Survivorship Program, St. Joseph’s Hospital Survivorship

Committee, Center Harbor, NH

03/29/2008 Nurse Measurement of Chemotherapy-Induced Peripheral Neuropathy (CIPN) and

Associated, NH Chapter Oncology Nursing Society, Lebanon, NH

04/01/2008 Assessment Chemotherapy-Induced Peripheral Neuropathy (CIPN): Which Measurement

Approaches are Best: Nursing Grand Rounds, Dartmouth-Hitchcock Medical Center,

Lebanon, NH

04/21/2009 Inch-by-Inch . . or is it Row by Row?, The Complexities of Measurement Science,

Dartmouth College Journal Club, Lebanon, NH

06/19/2009 Measuring the Quality of Nursing Care Related to Pain Management, Dartmouth-

Hitchcock Medical Center, Lebanon, NH

09/30/2009 Chemotherapy-Induced Peripheral Neuropathy and Associated Pain: Past, Present, &

Future Research Directions, University of Michigan Oncology Quality of Life Group,

Ann Arbor, MI

11/25/2009 The ADVANCE Trial: A Multicenter Validation Study of Biomarkers of Vincristine

Peripheral Neuropathy in Children with Acute Lymphoblastic Leukemia, University of

Michigan –MCRU (Michigan Clinical Research Unit), Ann Arbor, MI

03/01/2010 The ADVANCE Trial: A Multicenter Validation Study of Biomarkers of Vincristine

Peripheral Neuropathy in Children with Acute Lymphoblastic Leukemia, University of

Michigan –MCRU (Michigan Clinical Research Unit), Ann Arbor, MI

09/06/2012 Chronic Pain Across Populations, University of Michigan Nursing Grand Rounds,

Ann Arbor, MI

01/17/2013 Chronic Pain Across Populations, University of Michigan Nursing Leadership

Conference, Ann Arbor, MI

03/30/2015 Uncovering the Mysteries of Chronic Pain in Cancer Populations, University of Michigan

School of Nursing Dean’s Research Day, Ann Arbor, MI

3/17/2016 Midwestern Nursing Research Conference Symposium: Cancer Treatment-Related Pain

and Peripheral Neuropathy: Mechanisms, Measurement and Management - The

reliability, validity, and sensitivity of the European Organization for Research and

Treatment of Cancer (EORTC) Quality of Life Questionnaire-chemotherapy-induced

Peripheral Neuropathy (QLQ-CIPN-20).

3/22/18 Bedside to Bench to Bedside: Managing Painful Chemotherapy-Induced Chronic Pain,

University of Michigan/Michigan Medicine Palliative Care Research Conference

National Invited Presentations

05/1992 Self -Care Research, Oncology Nursing Society Congress, San Diego, CA

11/1992 Nursing Research Within CALGB, CALGB, Saint Louis, MO

05/1993 Dyspnea: Symptom Management and Life Quality, Oncology Nursing Society

Local Chapter, Boston, MA

05/1993 Nursing Research within CALGB, CALGB, Baltimore, MD

05/05/1994 Communicating Options Throughout The Lung Cancer Experience, Oncology Nursing

Society Annual Congress, Cincinnati, OH

05/06/1994 Overview of Non-Small-Cell Lung Cancer, Oncology Nursing Society Annual Congress,

Cincinnati, OH

03/12/1995 Dyspnea Management, Oncology Nursing Society Local Chapter, Stowe, VT


05/1996 Dyspnea and Quality of Life, CALGB, Miami, FL

10/1996 Patient Education Improvement Efforts at a Comprehensive Cancer Center, American

Association of Cancer Education, Chicago, IL

05/1998 Sleep Disturbances, Oncology Nursing Society Annual Congress, San Francisco, CA

05/2000 A Multidisciplinary Quality Improvement Approach to Improve Neuropathic

Pain Management in Cancer Patients, Oncology Nursing Society Annual Congress,

San Antonio, TX

06/2000 Lung Cancer: Diagnosis, Treatment, and Symptom Management, Pharmaceutical,

Boston, MA

06/2000 Lung Cancer: Diagnosis, Treatment, and Symptom Management, Pharmaceutical,

Peabody, MA

04/2001 Chemotherapy-Induced Peripheral Neuropathy: Assessment and Treatment,

Oncology Nursing Society Chapter, Burlington, VT

05/2001 CPT-11 and Lung Cancer, Pharmaceutical, Las Vegas, NV

02/04/2002, Chemotherapy-Induced Peripheral Neuropathy: Assessment and Treatment

11/25/2002 Strategies to Improve Patient Quality of Life, Pharmaceutical, National Teleconference


Oncology Nursing Society Chapter, Albany, NY

06/2002 Cooperative Group Nursing Research Summit, CALGB, Washington, DC


Oncology Nursing Society Chapter, Lowell, MA

11/2002 Glutamine for the Treatment of Peripheral Neuropathy, CALGB, Chicago, IL

12/2009- The Influence of Central and Peripheral Nervous System Side Effects on Cancer

10/2003 Therapy: A Patient-Focused Model for Change, Pharmaceutical,

National Teleconference

11/2004 Peripheral Neuropathy Measurement Approaches, CALGB, Atlanta, GA

12/13/2005 Multidisciplinary Care of Squamous Cell Carcinoma of the Head & Neck,

Pharmaceutical, Orlando, FL

05/2006 Evidence-Based Practice for Breast & Lung Cancer, Oncology Nursing Society Annual

Congress, Boston, MA

06/16/2006 A Celebration of CALGB Oncology Nursing, CALGB, Chicago, IL

10/19/2006 Cooperative Group Values, Mission, Aims, and Group Infrastructure –Multi-site Training

Program, Oncology Nursing Society, Washington, DC

02/10/2007 Frontiers of Research, Oncology Nursing Society Research Meeting, Hollywood, CA

9/14/2007 Developing a Cancer Survivorship Program, Florida Cancer Conference,

Palm Beach, FL


Measurement Approaches, University of Massachusetts, Boston, MA


Measurement Approaches, University of Utah, Salt Lake City, UT


Measurement Approaches, University of Michigan, Ann Arbor, MI


Measurement Approaches, University of Indiana, Indianapolis, IN

5/12/2009 The CARES Program: Cancer & Related Events Survivor Program; The Path to Program

Development, Hartford Hospital20th Annual Mary Mulready Sullivan


Oncology Symposium, Harford, CT

09/29/2009 Nursing Management of Cancer Treatment-Induced Peripheral Neuropathy: A Quality

Improvement Initiative, Rochester Oncology Clinic, Rochester, NY

11/30/2009 Nursing Management of Cancer Treatment-Induced Peripheral Neuropathy: A Quality

Improvement Initiative, Catholic Medical Center Oncology Nursing Society Chapter,

Bedford, NH

11/13/2010 New Perspectives in Oncology Practice - Peripheral Neuropathy Management, Reed

Medical Education, New York, NY

05/12/2011 Chemotherapy-Induced Peripheral Neuropathy – Implications for Nurses, North Central

Cancer Oncology Group, Mayo Clinic- Rochester, MN

06/25/2011 Chemotherapy-Induced Peripheral Neuropathy Measurement: Implications for

Cooperative Group Research, CALGB – Pharmacology Experimental Therapeutics

Committee, Boston, MA

10/08/2011 Chemotherapy-Induced Peripheral Neuropathy, ONS Survivor Series, Detroit, MI

11/13/2011 Chemotherapy-Induced Peripheral Neuropathy Measurement: Implications for

Cooperative Group Research, ECOG – Pharmacogenetic Committee, Ft. Lauderdale, FL

06/05/2012 ASCO Scientific Symposium Presentation: CALGB 170601: Results of a RCT Testing

Duloxetine for CIPN Pain, American Society of Clinical Oncology, Chicago, IL

06/29/2012 CALGB 170601: Results of a RCT Testing Duloxetine for CIPN Pain, The Alliance,

Chicago, IL

09/19/2012 CALGB 170601: Results, Successes, and Future Recommendations, NIH Symptom &

Quality of Life Steering Committee, Bethesda, MD

09/29/2012 Prevention and Management of Peripheral Neuropathy, ONS Hematology Regional

Conference, Indianapolis, IN

10/27/2012 Treatment of Chemotherapy-Induced Peripheral Neuropathy, Supportive Oncology

Conference, Chicago, IL

11/18/2012 Measuring Vincristine-Induced Neuropathy in Children (Research Podium), ONS

Connections Conference, Phoenix, AZ

12/09/2012 Invited Lecture: CALGB 170601: Results of a RCT Testing Duloxetine for CIPN Pain,

American Society of Hematology, Atlanta, GA

06/24/2013 Chronic Pain Across Populations, Rochester, NY Cancer Center, Rochester, NY

11/08/2013 Victoria Mock New Investigator Award Lecture, Oncology Nursing Society, Dallas, TX

03/21/2014 Cancer Treatment-Related Chronic Pain: Assessment, Treatment, and Prediction, Illinois

Medical Association, Chicago, IL

04/10/2014 Nurturing Excellence Through Nursing Research 2014, Ohio State University,

Columbus, OH

03/1/2017 NIH Symptom and Quality of Life Steering Committee: Invited CIPN Research Panelist

03/23/17 Analgesic, Anesthetic, and Addition Clinical Trial Translations, Innovations,

Opportunities and Networks: Invited CIPN Research Panelist

4/8-9/2019 Oncology Nursing Society Research Intensive Faculty, Anaheim California

3/10-13/2019 Visiting Professor – University of Southern Florida - Managing Painful Chemotherapy-

Induced Chronic Pain: Bedside to Bench to Bedside, University of Southern Florida

5/10/2019 Alliance Group Meeting - Managing Painful Chemotherapy-Induced Chronic Pain:

Bedside to Bench to Bedside, Chicago, IL

International Invited Presentations


08/1997 Dyspnea and Quality of Life, International Association for the Study of Lung Cancer;

Dublin, Ireland

07/2015 Chronic Pain Across Non-Communicable Disease Populations; Korat, Thailand

07/2015 IMMPACT Guided Approaches to Designing Chronic Pain Studies; Korat, Thailand

6/23/2016 Using Interdisciplinary Teams to Facilitate Research and Clinical Practice; Chiang Mai,

Thailand

6/24/2016 Putting Science into Teams – Keynote Lecture in Collaboration with Dean Kathleen

Potempa: Chiang Mai, Thailand

11/4/16 On Pins & Needles: VIPN Assessment, Characteristics and Patterns in Children with

Leukemia: POGO, Toronto, Canada

6/28/2018 Chemotherapy-Induced Peripheral Neuropathy Measurement Science: Vienna, Austria,

Multinational Association of Supportive Care in Cancer (MASCC) Conference

2/2019 Invited Lecture: Chemotherapy-Induced Peripheral Neuropathy and Associated Pain

Management – Bedside to Bench to Bedside - 4th International Conference on Prevention

and Management of Chronic Conditions – Bangkok, Thailand

BIBLIOGRAPHY

(aPeer Reviewed; bData-based; c BioMed Libraries designated all-time top 10 article published in my

domain, dSenior Author, eco-published with student or post-doctoral fellow)

Journals and Publications

1. Smith, E. L. (1992). Dyspnea and Quality of Life. In M. B. Whedon, & L. L. Powel (Eds.),

Quality of life: A nursing challenge, Physical Well-Being, 1(1):31-38.

2. Smith, E. L. (1998). Pulmonary Metastasis. In P. J. Haylock (Ed), Nursing Implications in the

Management of Patients with Metastatic Disease, Seminars in Oncology Nursing, 14(3), 178-186.

PMID: 9718643.

3. a,bMaurer, L. H., Davis, T., Hammond S., Smith, E., West, P., & Doolittle, M. (2001). Clinical

trials in a rural population: Professional Education Aspects. Journal of Cancer Education, 16(2),

89-92. PMID: 11440069.

4. a,bSmith, E. L., Hann, D. M., Ahles, T. A., Furstenberg, C. T., Mitchell, T. A., Meyer, L., Maurer,

L. H., Rigas, J., & Hammond, S. (2001). Dyspnea, Anxiety, Body Consciousness, and Quality of

Life of Patients with Lung Cancer. Journal of Pain and Symptom Management, 21(4), 323-328.

PMID: 11312047.

5. a,bSmith, E. L., Whedon, M., Bookbinder, M. (2002) Quality Improvement Approach of Painful

Peripheral Neuropathy. Seminars in Oncology Nursing, 18(1), 36-43. PMID: 11878038.

6. aSmith, E.L., Skosey, C, Armer, J., Berg, D., Cirrincione, C., & Henggeler, M. (2006). The

Cancer and Leukemia Group B Oncology Nursing Committee (1983-2006): A History of Passion,

Commitment, Challenge, and Accomplishment. Clinical Cancer Research, 12(11), 3638s-3641s.

PMID: 16740799.

7. aSmith, E. L., Beck, S. L., & Cohen, J. A. (2008). The Total Neuropathy Score (TNS): A Tool for

Use by Oncology Nurses When Measuring Chemotherapy-Induced Peripheral Neuropathy.

Oncology Nursing Forum, 35 (1), 96-102. PubMed PMID: 18192158.

8. a,d Schaal, A. D., Skalla, K. A., Mulrooney, T. J., Stearns, D., & Smith, E. M. L. (2008). Building a

collaboration of hematology-oncology advanced practice nurses. Part II: Outcomes. Oncology

Nursing Forum, 35, (6), 875-878. PMID: 18980918.


9. a,bSmith, E. L., Bakitas, M., Homel, P., Fadul, C., Skalla, K., Meyer, L., & Bookbinder, M. (2009).

Using Quality Improvement Methodology to Improve Neuropathic Pain Screening and Assessment

in Patients with Cancer. Journal of Cancer Education, 24(2), 135-140. PMID: 19431031.

(November 26, 2012 - 2nd most downloaded article in the Journal’s history)

10. *a,b,cSmith, E. L., Cohen, J. A., Pett, M. A., & Beck, S. L. (2010). The Reliability and Validity of a

Modified Total Neuropathy Score-Reduced (TNSr) and Neuropathic Pain Severity Items When Used

to Measure Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving Taxanes

and Platinums. Cancer Nursing, 33(3), 173-182. PMID: 20357656.

11. a,bBeck, S. L., Towsley, G. L., Berry, P. H., Brant, J. M., Smith, E. L. (2010) Measuring the quality

of care related to pain management: A multiple method approach to instrument development.

Nursing Research, 59(2), 85-92. PubMed PMID: 20216010.

12. a,bBeck, S. L., Towsley, GL, Pett, M, Berry, P. H., Smith, E. L., Brant, J. M., Guo, J. W. (2010).

Initial psychometric properties of the Pain Care Quality (PainCQ) Survey. Journal of Pain, 11(12),

1311-1319. PMID: 20537957.

13. *a,b,cSmith, E. L., Cohen, J. A., Pett, M. A., & Beck, S. L. (2011). The Validity of Chemotherapy-

Induced Peripheral Neuropathy (CIPN) Measurement Approaches When Used to Assess Taxane and

Platinum-Induced Peripheral Neuropathy in Oncology Outpatients. Oncology Nursing Forum,

38(2), 133-142. PMID: 21356652.

14. *a,bSmith, E. L., Bakitas, M. A., Homel, P., Piehl, M., Kingman, L., Fadul, C., & Bookbinder, M.

(2011). Preliminary Assessment of a Neuropathic Pain Treatment and Referral Algorithm for

Patients with Cancer. Journal of Pain and Symptom Management, 42(6), 822-838. PMID:

21820851.

15. a,b Smith, E. M. L., Skalla, K., Li, Z., Onega, T., Anton, K., Gallagher, S., Rhoda, J., Gates, C., &

Scott, M. R. (2012). Assessing cancer survivors’ needs using web-based technology: A pilot study.

Computer Informatics Nursing, 30(2). 71-81. PMID: 22258317.

16. a,bPett, M. A., Beck, S. L., Guo, J. W., Towsley, G. L., Brant, J. M., Lavoie Smith, E. M., Berry, P.

H., & Donaldson, G. (2013). Confirmatory factor analysis of the Pain Care Quality Survey

(PainCQ©). Health Services Research, 48(3), 1018-1038. EPub 3 Dec 2012, DOI: 10.1111/1475-

6773.12014. PMID: 23205503; PMCID: PMC3681241.

17. aSmith, E. L. (2013). Current Methods for Assessment and Management of Taxane-Associated

Chemotherapy-Induced Peripheral Neuropathy. Clinical Journal of Oncology Nursing, Suppl 17(1),

22-34. PMID: 23360700.

18. a,bSkalla, K; Smith, E. L., Li, Z., & Gates, C., & Litterini, A. (2013). Multidimensional Needs of

Caregivers for Patients With Cancer. Clinical Journal of Oncology Nursing. DOI

10.1188/13.CJON.17-05AP. PMID: 23956004.

19. a,bSmith, E. L., Barton, D. L., Qin, R., Aaronson, N. K., & Loprinzi, C. L. (2013). Assessing

patient-reported peripheral neuropathy: The reliability and validity of the European Organization for

Research and Treatment of Cancer QLQ-CIPN20 Questionnaire. Quality of Life Research. DOI

10.1007/s11136-013-0379-8. PMID 23543373, NIHMSID 568510.

20. a,bSmith, E. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Bressler, L. R.,

Fadul, C., Knox, C., Gilman, P. B., Shapiro, C. L. (2013). Effect of duloxetine on pain, function,

and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: A

randomized clinical trial. JAMA, 309(13), 1359 – 1367. PMID: 23549581; PMC3912515. NIHMSID

527232.

a. Featured in the JAMA Report (April 3, 2013) – A television clip highlighting this study

was aired on 183 television stations throughout the United States and was viewed by over


17 million viewers and 82 million viewers viewed the video clip on-line.

http://jama.jamanetwork.com/journal.aspx; http://www.nursing.umich.edu/about-our-

school/news-portal/201304/2978#.UVwrTPUr27s.

b. http://www.everydayhealth.com/sanjay-gupta/the-legacy-of-chemo-that-can-last-for-

years-pain.aspx

21. a,bSmith, E. L., Li, L., Hutchinson, R., Ho, R., Burnette, W. B., Wells, E., Bridges, C., & Renbarger,

J. (2013). Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic

leukemia. Cancer Nursing. doi:10.1097/NCC.0b013e318299ad23. NIHMS487762, Publ.ID:

NCC200489 PMID: 2384252. PMCID: PMC3951303. NIHMSID 487762.

22. aSmith, E. M. L and Pang, H. (2013). Response to Letter to the Editor: Effect of duloxetine on pain

in chemotherapy-induced peripheral neuropathy. JAMA, 310 (5), 538-538. PMID: 23925632.

23. Cirrincione, C. T., Lavoie Smith, E. M., & Pang. H. (2014). Methodological considerations in the

design and implementation of clinical trials. Seminars in Oncology Nursing, 30(1):74-79. PMID:

24559783; PMCID: PMC3980716.

24. dKottschade, L. A., Bell, J., Klinger, K., & Smith, E. M. (2014). Nursing’s presence amidst the

changing cancer cooperative group landscape. Seminars in Oncology Nursing, 30(1), 32-37. PMID:

24559778.

25. a,bHershman, D., Lacchetti, C., Dworkin, R., Smith, E., Bleeker, J., Cavaletti, G., Chauhan, C.,

Gavin, P., Lavino, A., Lustberg, M., Paice, J., Schneider, B., Smith, T., Terstriep, S., Johnson, N.

W., Bak, K., & Loprinzi, C. L. (2014). Prevention and management of chemotherapy-induced

neuropathy in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice

Guideline. Journal of Clinical Oncology. doi:JCO.2013.54.0914. PMID: 24733808.

26. a,dBridges, C. M. & Smith, E. M. L. (2014). What about Alice? Peripheral neuropathy from taxane-

containing treatment for advanced non-small-cell lung cancer. Supportive Care in Cancer. DOI

10.1007/s00520-014-2317-x. PMID:24952242.

27. a,b,eSmith, E. M. L., Campbell, G., Tofthagen, C., Kottschade, L., Collins, M. L., Wharton, C.,

Ghosh, B., Ronis, R. L., Mallory, G. A., & Visovsky, C. (2014). Nursing knowledge, practice

patterns, and learning preferences regarding chemotherapy-induced peripheral neuropathy.

Oncology Nursing Forum, 41(6), 669–679. doi: 10.1188/14.ONF.669-679. PMID: 25355022.

28. Smith, E. M. L., Bridges, C. M., Kanzawa, G., Knoerl, R., Kelly, J. P., Berezovsky, A., & Woo, C.

(2014). Cancer treatment-related neuropathic pain – epidemiology and treatment: An update.

Current Pain and Headache Reports, 18 (459). doi 10.1007/s11916-014-0459-7. PMID: 25239766.

29. a,b,eVoepel-Lewis, T., Zikmund-Fisher, B., Smith, E. L., Zyzanski, S., & Tait, A. R. (2014 Epub

ahead of print). Parents’ Analgesic Trade-off Dilemmas: How Analgesic Knowledge Influences

their Decisions to give Opioids. International Clinical Journal of Pain. PMID: 25232863.

30. a,b,eVoepel-Lewis, T., Zikmund-Fisher, B., Smith, E. L., Redmund, R., Zyzanski, S., & Tait, A. R.

(2015). Opioid-related adverse events: Do parents recognize the signals? The Clinical Journal of

Pain. 31(3), 198-205. PMID: 24810650.

31. a,bPachman, D., Qin, R., Seisler, D., Smith, E. M. L., Beutler, A. S., Ta, L. E., Lafky, J., Johnston,

N. W., Ruddy, K., Bernath, A. M., Grothey, A., Loprinzi, C. (2015). Clinical Course of Oxaliplatin-

Induced Neuropathy – Results from the Randomized Phase III Trial N08CB (Alliance). Journal of

Clinical Oncology. 20; 33(30):3416-22. doi: 10.1200/JCO.2014.58.8533. PMID: 26282635.

32. a,b,eVoepel-Lewis, T., Zikmund-Fisher, B., Smith, E. L., Zyzanski, S., & Tait, A. R. (2015).

Parents’ Preferences Influence their Decisions to Withhold Opioids when Faced with Analgesic

Trade-off Dilemmas. Clinical Journal of Pain. 52(8):1343-53. doi: 10.1016/j.ijnurstu.2015.05.003.

PMID: 26001855.

http://jama.jamanetwork.com/journal.aspx

http://www.nursing.umich.edu/about-our-school/news-portal/201304/2978#.UVwrTPUr27s

http://www.nursing.umich.edu/about-our-school/news-portal/201304/2978#.UVwrTPUr27s

http://www.everydayhealth.com/sanjay-gupta/the-legacy-of-chemo-that-can-last-for-years-pain.aspx

http://www.everydayhealth.com/sanjay-gupta/the-legacy-of-chemo-that-can-last-for-years-pain.aspx


33. a,b,eSmith, E. M. L., Li, L., Chiang, C ., Thomas, K., Hutchinson, R., Wells, E. M., Ho, R. H.,

Skiles, J., Chakraborty, A., Bridges, C. M., & Renbarger, J. (2015). Patterns and severity of

vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. Journal of

the Peripheral Nervous System, 20(1), 37-46. doi: 10.1111/jns.12114. PMID: 25977177. NIHMSID

725958.

34. a,b,eSchymik, F. A., Voepel-Lewis, T., & Smith, E.L. (2015). Parental Opioid Decision Making for

Children with and without Obstructive Sleep Apnea who underwent Tonsillectomy and

Adenoidectomy. Pain Management Nursing. 16(6):881-889. PMID: 26697816.

35. a,b,d,eKnoerl, R., Smith, E. L. (2015). Chronic Pain and Cognitive Behavioral Therapy: An

Integrative Review. Western Journal of Nursing Research. pii: 0193945915615869. [Epub ahead of

print]. PMID: 26604219.

36. a,bSmith, E. M. L., Pang, H., Ye, C., Cirrincione, C., Fleishman, S., Paskett, E. E., Ahles, T.,

Bressler, L. R., Le-Lindqwister, N., Fadul, C. E., Loprinzi C., & Shapiro, C. L. (2015). Predictors of

Duloxetine Response In Patients with Painful Oxaliplatin-Induced Peripheral Neuropathy (CIPN): A

Secondary Analysis of CALGB/Alliance 170601. European Journal of Cancer Care. PMID:

26603828 PMCID: PMC4879099. NIHMSID 775228.

37. a,bBeck, S. L., Brant, J. M., Donahue, R., Smith, E. M. L., Towsley, G. L., Berry, P. H., Guo, J-W.,

AI-Qaaydeh, S., Pett, M. A., & Donaldson, G. (2016). Oncology Nursing Certification: Relation to

Nurses' Knowledge and Attitudes about Pain, Patient-Reported Pain Care Quality, and Pain

Outcomes. Oncology Nursing Forum. 43(1), 67-76. doi:10.1188/16.ONF.67-76; PMID: 26679446.

38. a,b Pachman, D. R., Qin, R., Seisler, D., Smith, E. M. L., Puttabasavaiah, S., Novotny, P., Ruddy,

K., Beutler, A. S., Johnston, N. D. W., Staff, N., Grothey, A., Dougherty, P., Bennett, G., Cavaletti,

G., Loprinzi, C. L. (2016). Comparison of Oxaliplatin and Paclitaxel Induced Neuropathy.

Supportive Care in Cancer. 24(12), 5059-5068. PMID: 27534963.

39. a,b,d,eKnoerl, R., Dudley, W., Smith, G., Bridges, C., Kanzawa, G., & Smith, E. M. L. (2016). Pilot

Testing a Web-Based System for the Assessment and Management of Chemotherapy-Induced

Peripheral Neuropathy. Computers Informatics Nursing. PMID: 28002115 DOI:

10.1097/CIN.0000000000000320.

40. eMora, E., Smith, E. M. L., Mody, R., Donohue, C., & Hertz, D. (2016). Vincristine-Induced

Peripheral Neuropathy. 6(11):2416-2430. American Journal of Cancer Research. PMID: 27904761

PMCID: PMC5126263.

41. a,b,d,eKnoerl, R., Lee, D., Yang, J., Kanzawa-Lee, G., Bridges, C., Smith, G., & Lavoie Smith, E. M.

L. (2017). Examining the Impact of a Web-Based Intervention to Promote Patient Activation in

Chemotherapy-Induced Peripheral Neuropathy Assessment and Management. Journal of Cancer

Education. doi: 10.1007/s13187-017-1200-0. [Epub ahead of print] PMID: 28265863.

42. a,b,d,eKnoerl, R., Gray, E., Stricker, C., Mitchell, S. A., Kippe, K., Smith. G., Dudley, W. N., &

Smith, E. M. L. (2017). Electronic versus Paper-Pencil Methods for Assessing Chemotherapy-

Induced Peripheral Neuropathy. Supportive Care in Cancer. PMID: 28577231 DOI:

10.1007/s00520-017-3764-y.

43. a,b,eSmith, E. M. L., Haupt, R., Kelly, J. P., Lee-Ekblad, D., Kanzawa, G., Knoerl, R., Bridges, C.,

Alberti, P., Prasertsri, N., & Donohoe, C. (2017). The Content Validity of a Chemotherapy-Induced

Peripheral Neuropathy Patient-Reported Outcome Measure. Oncology Nursing Forum. 44(5):580-

588. doi: 10.1188/17.ONF.580-588. PMID: 28820525. PMCID: PMC5913659. NIHMSID 960212.

44. a,b,d,e Knoerl, R., Yang, J., Barton, D., Williams, D. A., Holden, J. E., Krauss, J. C., LaVasseur, B.,

& Smith, E. M. L. (2017). Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-


Induced Peripheral Neuropathy: A Multicenter, Randomized, Wait-List Controlled Trial. Journal of

Pain. DOI: 10.1016/j.jpain.2017.11.009, PMID: 29229430.

45. a,b Le-Rademacher, J., Kanwar, R., Seisler, D., Pachman, D. R., Abyzov, A., Ruddy, K.J., Banck,

M. S., Smith, E. M. L., Dorsey, S. G., Aaronson, N. K., Sloan, J., Loprinzi, C. L., & Beutler, A. S.

(2017). Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification

of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical

trials. Supportive Care in Cancer. (11):3537-3544. doi: 10.1007/s00520-017-3780-y. Epub 2017 Jun

20. PMID: 28634656 PMCID: PMC5693734.

46. a,b,ePrasertsri, N., Kaewmanee, C., Khantittichit, P., Triyaphan, W., Smith, E. M. L, Lun, C. W., &

Diligently, B. (2017). Chemotherapy-Induced Peripheral Neuropathy (CIPN): A cross-sectional

study in Cancer Patients. Journal of Nursing, Public Health, and Education. 18 (3).ISSN: 2651-1908

Journal Online.

47. a,bSkiles, J.L., Li, C. H., Chien C. W., Smith, E. M. L., Olbara, G., Jones, D. R., Vik, T. A.,

Mostert, S., Abbink, F., Kaspers, G. J., Li, L. Njuguna, F., Sajdyk, T., & Renbarger, J. L. (2018).

CYP3A5 genotypeand its impact on vincristine pharmacokinetics and development of neuropathy in

Kenyan children with cancer. Pediatric Blood & Cancer. 65(3) doi: 10.1002/pbc.26854. PMID:

29115708, PMCID: PMC5766375.

48. a,bSmith, E. M. L., Banerjee, T., Yang, J., Bridges, C., Alberti, P., Sloan, J., & Loprinizi, C. (2018).

Psychometric Testing of the European Organisation for Research and Treatment of Cancer (EORTC)

QLQ-CIPN20 Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures

Standardization (CI-PeriNomS) and Alliance for Clinical Trials in Oncology (Alliance) A151408

Study Data. Cancer Nursing. PMID: 29649081 DOI: 10.1097/NCC.0000000000000596. NIHMSID

960208.

49. a,b,d,e Knoerl, R., Smith, E. M. L., & Chornoby, Z. (2018). Estimating the Frequency, Severity, and

Clustering of SPADE Symptoms in Chronic Painful Chemotherapy Induced Peripheral Neuropathy

(CIPN). Pain Management Nursing. doi:10.1016/j.pmn.2018.01.001. PMID: 29503217

50. a,b,e Smith, E. M. L., Knoerl, R., Yang, J., Kanzawa-Lee, G., & Bridges, C. (2018). In Search of a

Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy-Induced Peripheral

Neuropathy Clinical Trials. Cancer Control. PMID: 29480026 DOI: 10.1177/1073274818756608.

NIHMSID 960208.

51. a,b,d,e Kanzawa-Lee G, Harte S, Bridges C, Clauw DJ, Williams DA, Knoerl R, Lavoie Smith, EM.

Pressure Pain Phenotypes in Women Before Breast Cancer Treatment. (2018). Oncology Nursing

Forum. 45(4):483-495. doi:10.1188/18.ONF.483-495. PMID: 29947358

52. a,b,d,e Knoerl, R., Barton, D. L., Holden, J. E., Krauss, J., LaVasseur, E., & Smith, E.M.L. (2018).

Potential Mediators of Improvement in Painful Chemotherapy-Induced Peripheral Neuropathy via a

Web-based Cognitive Behavioral Intervention. Can Oncol Nurs J / Rev Can soins Infirm en Oncol.

28(3):178-183.

53. a,b,d,e Knoerl, R., Bridges, C., Lita Smith, G., Yang, J.J., & Kanzawa-Lee, G, & Smith, E.M.L.

(2018). Use of an Electronic Oncology Care Planning System to Improve Adherence to

Recommended Chemotherapy-Induced Peripheral Neuropathy Assessment and Management

Practices. Clinical Journal of Oncology Nursing. 22(5), E134 – E140.

54. a,b,eSmith, E. M. L., Zanville, N., Kanzawa-Lee, G., Donohoe, C., Bridges, C. M., Loprinzi, C., &

Yang, J. J. (2018). Rasch Analysis of the EORTC-QLQ CIPN20 Patient-Reported Outcome Measure

of Chemotherapy-Induced Peripheral Neuropathy. Supportive Care in Cancer. DOI:

10.1007/s00520-018-4553-y. PMID 30460399


55. a,b Henry, N. L, Kidwell, K., Alsamarraie, C., Bridges, C. M., Kwiatkowski, C. K., Clauw, D. J.,

Smith, E. M. L., & Williams, D. A. (2018). Pilot Study of an Internet-based Self-Management

Program for Symptom Control in Patients with Early Stage Breast Cancer. JCO Clinical Cancer

Informatics. doi: 10.1200/CCI.17.00106. PMID: 30652562.

56. a,b,ePhligbuaa, W., Smith, E. M. L., & Barton, D. (2018). Psychometric properties of the Menopause

Specific Quality of Life Questionnaire among Thai women with a history of breast cancer. European

Journal of Oncology Nursing. 36:75-81. doi: 10.1016/j.ejon.2018.08.008. PMID: 30322513.

57. a,b Hertz, D. L., Kidwell, K. M., Vangipuram, K., Li, F., Pai, M. P., Burness, M., Griggs, J., Schoot,

A., Van Poznak, C., Hayes, D. F., Smith, E. M. L., & Henry, N. L. (2018). Paclitaxel plasma

concentration after the first infusion predicts treatment-limiting peripheral neuropathy. Clinical

Cancer Research. 24(15). doi: 10.1158/1078-0432.CCR-18-0656. PMID: 29703818.

58. aGewandter, J. S., Brell, J., Cavaletti, G., Dougherty. P., Evans, S., Howie, L., McDermotta, M. P.,

O’Mara, A., Smith, A. G., Dastros-Pitei, D., Gauthier, L., Haroutounian, S., Jarpe, M., Katz, N. P.,

Loprinzi, C., Richardson, R., Smith, E. M. L., Wen, P., Turk, D. C., Dworkin, R. H., Freeman, R.

(2018). Clinical Trial Design for Prevention of Chemotherapy-induced Peripheral Neuropathy:

ACTTION Recommendations. Neurology .91(9). doi: 10.1212/WNL.0000000000006083. PMID:

30054438 PMCID: PMC6133627.

59. a,b Sun, Y., Kim, J. A., Vangipuram, K., Hayes, D. F., Smith, E. M. L., Yeomans, L., Henry, N. L.,

Stringer, K. A., and Hertz, D. L. (2018). Pharmacometabolomics Reveals a Role for Histidine,

Phenylalanine and Threonine in the Development of Paclitaxel-induced Peripheral Neuropathy.

Breast Cancer Research and Treatment. 171(3): 657-666. doi: 10.1007/s10549-018-4862-3. PMID:

29946863 PMCID: PMC6119501.

60. a,b,d,e Kanzawa, G., Harte, S., Bridges, C. M., Brummett, C., Clauw, D., Williams, D., Knoerl, R., &

Smith, E. M. L. (2018). Trauma Exposure Predicts Cancer Treatment-Related Pain in Breast Cancer

Survivors. Cancer Nursing. doi: 10.1097/NCC.0000000000000687. [Epub ahead of print]. PMID:

30601264.

61. a,d,e Donohoe, C., & Smith, E., M. L. (2018). Psychological Predictors of Pain in Children and

Adolescents with Sickle Cell Disease: A Scoping Review. Journal of Pediatric Oncology Nursing.

doi: 10.1177/1043454218819457. [Epub ahead of print]. PMID: 30565483.

62. a,bLi, L., Sajdyk, T., Smith, E. M. L., Chang, C. W., Li, C., Ho, R. H., Hutchinson, R., Wells, E., &

Renbarger, J. L. (2018). Genetic Variants Associated with Vincristine-Induced Peripheral

Neuropathy in Two Independent Populations of Children with Acute Lymphoblastic Leukemia.

Clinical Pharmacology and Therapeutics. 105(6); 1421-1428. doi: 10.1002/cpt.1324. PMID:

30506673.

63. a,d,eNgamkham, S., Holden, J. E., & Smith, E. L. (2019). Mindfulness intervention for cancer-

related pain. Asia Pacific Journal of Oncology Nursing. 6; 161-169.

64. a,d,e Lee, D., Kanzawa-Lee, G., Knoerl, R., Wyatt, G., and Smith, E. M. L. (2019). Internal and

External Threats to Validity in Phase III Prevention and Treatment Trials of Chemotherapy-Induced

Peripheral Neuropathy: A Systematic Review. Asia-Pacific Journal of Oncology Nursing. Accepted

for publication 4 – 23 – 2019.

65. Smith, E. M. L. (2019). Pharmacologic treatments for chronic cancer-related pain: Does anything

work? Editorial. Journal of Clinical Oncology. [Epub ahead of print]. doi.

http://ascopubs.org/doi/full/10.1200/JCO.18.01567

66. aDorsey, S. G., Kleckner, I. R., Barton, D., Mustian, K., O-Mara, A., St. Germain, D., Cavaletti, G.,

Danhauer, S., Hershman, D., Hohmann, A., Hoke, A., Hopkins, J., Kelly, K., Loprinzi, C., McLeod,

H., Mohile, S., Paice, J., Rowland, J., Salvemini, D., Segal, R., Smith, E. L., Stevens, W. M., &


Janelsins, M. C. (2019). Commentary: Recommendations for planning clinical trials to prevent or

treat chemotherapy-induced peripheral neuropathy (CIPN). Journal of National Cancer Institute.

Accepted 1/23/19.

67. a,d,e Kanzawa-Lee, G., Donohoe C., Knoerl, R., Bridges, C. M., & Smith, E. M. L. (2019).

Mechanisms, predictors, and challenges in assessing and managing painful chemotherapy-induced

peripheral neuropathy. Seminars in Oncology Nursing. 35, 253-260.

68. a,b Knoerl, R., Smith, E.M.L., Han, A., Doe, A., Scott, K., Berry, D. (2019). Characterizing Patient-

Clinician Chemotherapy-Induced Peripheral Neuropathy Assessment and Management

Communication Approaches. Patient, Education, Counseling. Accepted for publication 4 – 5 – 2019.

69. aPotempa, K., Furspan, P., Rajataramya, B., Barton, D., Singha-Dong, N., & Stephenson, R.,

Smith, E. M. L., Davis, M., Dinov, I., Hampstead, B., Saslow, L., Aikens, J. (2019). Impact of using

a broad-based multi-institutional approach to build capacity for non-communicable disease research

in Thailand. Health Research Policy and Systems. Accepted for publication 5 – 19 – 2019.

70. a,bSajdyk, T. J., Boyle, F. A., Foran, K. S., Yan Tong, Y., Pandya, P., Smith, E. M. L., Ho, R.,

Wells, E., & Renbarger, J. L. (In Press). Obesity as a Potential Attribute for Vincristine Induced

peripheral Neuropathy. Pediatric Blood & Cancer. Accepted for publication 7 – 10 – 2019.

71. a,b,d,e Soulia, S., Duffy, E., Morley, K., & Smith, E. M. L. (In Press). Implementation of a

Survivorship Care Plan Program in a Community-Based Oncology Clinic. Journal of the Advanced

Practitioner in Oncology. Accepted for publication 7 – 11 – 2019.

72. a,b,d Kanzawa, G. & Smith, E. M. L. (In Press). Exercise interventions for chemotherapy-induced

peripheral neuropathy: A literature review. Cancer Nursing. Accepted for publication 12 – 06 –

2019.

73. a,bMarcath, L. A., Kdwell, K. M., Smith, E. M. L., Vangipuram, K., Gersch, C., Burness, M. L.,

Griggs, J. J., Schott, A. F., Van Poznak, C., Hayes, D. F., Henry, N. L., Beutler, A. S., & Hertz, D.

(In Press). L. EPHA genetics for prediction of paclitaxel-induced peripheral neuropathy sensitivity..

British Journal of Clinical Pharmacology. Accepted for publication 12 – 2019.

74. Wang, H-L., Cousin, L., Fradley, M. G, Donovan, K. A., Smith, B., Smith, E. M. L., & Buck, H. G.

(In Press). Exercise interventions in cardio-oncology populations: A scoping review of the literature.

Journal of Cardiovascular Nursing. 12 – 09 – 2019.

75. a,d,eKnoerl, R., Gilchrist, L., Kanzawa-Lee, G., Donohoe, C., Bridges, C., & Lavoie Smith, E. M.

(2020). Practice rehabilitation for chemotherapy-induced peripheral neuropathy. Seminars in

Oncology Nursing. Jan 18:150983. doi: 10.1016/j.soncn.2019.150983. [Epub ahead of print]

76. a,b,d,eSmith, E. M. L, Donohoe, C., Kanzawa-Lee, G., Alberti, P., Cavaletti, G., Saad, R., Bridges,

C., & Park, S. (In Press). Pediatric chemotherapy-induced peripheral neurotoxicity measurement

approaches: A systematic review. Lancet Heamatology.

Book Chapters

1. Smith, E. L. Cancer Pain (2004). In C. Varricchio (Ed), A Cancer Source Book for Nurses, Eighth

Edition. American Cancer Society, Atlanta GA.

2. Smith, E. L., & Ferrans, C. E. (2009). The Role of Cooperatives in Advancing Oncology Nursing

Science. In Advancing Oncology Nursing Science. Pittsburgh: Oncology Nursing Society

Publishing Company.

3. Smith, E.M. L. (2010). Peripheral Neuropathy. In L. K. Sheldon (Ed), The Cancer Survivorship

Series. Boston MA: Jones & Bartlett Publishers.


4. Smith, E.L., & Cohen, J. (2011). Neuropathies in cancer survivors. In J. Lester & P. Schmitt (Eds.),

Cancer rehabilitation and survivorship: Transdisciplinary approaches to personalized care.

Pittsburgh, PA: Oncology Nursing Society.

5. Smith, E.L, & Zanville, N. (2015). Peripheral Neuropathy. In C. Brown (Ed.), A Guide to

Oncology Symptom Management. Pittsburgh, PA: Oncology Nursing Society.

Other Media

Lay Media Article Highlight

1. a,bSmith, E. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Fadul, C., Knox,

C., & Shapiro, C. L for the Cancer and Leukemia Group B. (2012). Abstract 91721: CALGB

170601: A phase III double blind trial of oral duloxetine for treatment of painful chemotherapy-

induced peripheral neuropathy (CIPN). (Abstract 91721). Proceedings of the American Society of

Clinical Oncology (ASCO). Accepted for Scientific Symposium Presentation and ASCO Press

Program Presentation.

Highlighted in the lay media June 2012:

1. New York Times - http://www.nytimes.com/2012/06/04/health/glaxosmithkline-

melanoma-drug-prolongs-patients-lives.html?_r=1

2. US News and World Report - http://health.usnews.com/health-

news/news/articles/2012/06/04/antidepressant-cymbalta-might-ease-chemo-linked-pain

3. WebMD - http://www.webmd.com/cancer/news/20120604/cymbalta-may-relieve-chemo-

induced-pain-tingling

4. Medical News Today - http://www.medicalnewstoday.com/articles/246218.php

5. Bioscience Today - http://biosciencetechnology.com/News/2012/06/Antidepressant-

Drug-Duloxetine-Helps-Relieve-Pain-from-Chemotherapy,-Study-Finds/

6. HealthFinder.gov - http://www.healthfinder.gov/news/newsstory.aspx?Docid=665382

7. Cancer Survivors Network - http://csn.cancer.org/node/241316

8. Doctor’s Lounge - http://www.doctorslounge.com/index.php/news/hd/29542

9. Rx List - http://www.rxlist.com/script/main/art.asp?articlekey=158965

10. medpage Today -

http://www.medpagetoday.com/HematologyOncology/Chemotherapy/33078

11. KLAS CBS New- Nevada - http://www.8newsnow.com/story/18691536/antidepressant-

cymbalta-might-ease-chemo-linked-pain

12. MedicineNet.com - http://www.medicinenet.com/script/main/art.asp?articlekey=158901

13. ThirdAge.come - http://www.thirdage.com/breast-cancer/cymbalta-for-post-chemo-pain

14. CFVS CBS News - http://www.kfvs12.com/story/18691536/antidepressant-cymbalta-

might-ease-chemo-linked-pain

15. eCancerNews - http://ecancer.org/news/2892

16. WAFB CBS News - http://www.wafb.com/story/18691536/antidepressant-cymbalta-


17. Myfox Austin - http://www.myfoxaustin.com/story/18691536/antidepressant-cymbalta-


18. Fox 12 Oregon - http://www.kptv.com/story/18691536/antidepressant-cymbalta-might-

ease-chemo-linked-pain

19. Medical Daily - http://medicaldaily.com/news/20120604/10143/antidepressant-

duloxetine-chemotherapy.htm

http://www.nytimes.com/2012/06/04/health/glaxosmithkline-melanoma-drug-prolongs-patients-lives.html?_r=1

http://www.nytimes.com/2012/06/04/health/glaxosmithkline-melanoma-drug-prolongs-patients-lives.html?_r=1

http://health.usnews.com/health-news/news/articles/2012/06/04/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://health.usnews.com/health-news/news/articles/2012/06/04/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.webmd.com/cancer/news/20120604/cymbalta-may-relieve-chemo-induced-pain-tingling

http://www.webmd.com/cancer/news/20120604/cymbalta-may-relieve-chemo-induced-pain-tingling

http://www.medicalnewstoday.com/articles/246218.php

http://biosciencetechnology.com/News/2012/06/Antidepressant-Drug-Duloxetine-Helps-Relieve-Pain-from-Chemotherapy,-Study-Finds/

http://biosciencetechnology.com/News/2012/06/Antidepressant-Drug-Duloxetine-Helps-Relieve-Pain-from-Chemotherapy,-Study-Finds/

http://www.healthfinder.gov/news/newsstory.aspx?Docid=665382

http://csn.cancer.org/node/241316

http://www.doctorslounge.com/index.php/news/hd/29542

http://www.rxlist.com/script/main/art.asp?articlekey=158965

http://www.medpagetoday.com/HematologyOncology/Chemotherapy/33078

http://www.8newsnow.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.8newsnow.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.medicinenet.com/script/main/art.asp?articlekey=158901

http://www.thirdage.com/breast-cancer/cymbalta-for-post-chemo-pain

http://www.kfvs12.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.kfvs12.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://ecancer.org/news/2892

http://www.wafb.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.wafb.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.myfoxaustin.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.myfoxaustin.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.kptv.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.kptv.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://medicaldaily.com/news/20120604/10143/antidepressant-duloxetine-chemotherapy.htm

http://medicaldaily.com/news/20120604/10143/antidepressant-duloxetine-chemotherapy.htm


20. WECT - http://www.wect.com/story/18691536/antidepressant-cymbalta-might-ease-

chemo-linked-pain

21. Drug Policy Central - http://drugpolicycentral.com/bot/article/webmd8277.htm

22. WATE – Knoxville - http://www.wate.com/story/18691536/antidepressant-cymbalta-


23. WGEM - http://www.wgem.com/story/18691536/antidepressant-cymbalta-might-ease-

chemo-linked-pain

24. CBS Atlanta - http://www.cbsatlanta.com/story/18691536/antidepressant-cymbalta-


25. Yahoo Daily News -

http://article.wn.com/view/2012/06/04/Antidepressant_Cymbalta_Might_Ease_ChemoLi

nked_Pain/

26. Fox 8 New Orleans - http://www.fox8live.com/story/18691536/antidepressant-cymbalta-


27. Michigan Record - http://www.ur.umich.edu/update/archives/120606

28. NCI Bulletin - http://www.cancer.gov/ncicancerbulletin/061212

29. Cure Magazine 2014

2. 2016-2107 - ASCO University Grant Writing On-line Training Course Faculty

http://university.asco.org/grant-writing

Monographs

1. Sarna, L., Smith, E. L., Frankel, C. Rittenberg, C. N., Varricchio, C., & Wilkie, D. (1996).

Overview of Non-small Cell Lung Cancer (Module One). Vancouver: GlaxoWellcome.

2. Varricchio, C., Frankel, C., Rittenberg, C. N., Sarna, L., Smith, E. L., & Wilkie, D. (1997).

Assessing Quality of Life in Non-small Cell Lung Cancer Patients (Module Two). Vancouver:

GlaxoWellcome.

3. Lung Cancer Primer and CD-ROM, Evolution Health Care , 2002

4. Meniscus On-Line Lung Cancer Module for MDs and Nurses, 2002

5. Finding the Balance: Providing Patient-Driven Evidence-Based Treatment and Care, Oncology

Nursing Society, 2007

Letters/Other

1. Smith, E. L. (1990). Patient education of cancer patients. Research Review: Studies for Nursing

Practice, 7(3):2.

2. Smith, EL. (1992). Acute Respiratory Distress Syndrome. CALGB Newsletter, Fall, 1:5.

3. Smith, E. L., & Hammond, S. (1994). Chemoprevention of Second Primary Lung Cancers: A

Recruitment Strategy for CALGB 9293. CALGB Newsletter, Summer, 3(2):10.

4. Smith, E. L. (1996). Informed Consent: What does it mean? CALGB Newsletter, Fall, 5(3):6.

5. Smith EL. Commentary on Treatment of elderly patients with small cell lung cancer [original

article by Keane R appears in LUNG CANCER 1993;9(Suppl 1):S91-8]. ONS Nursing Scan in

Oncology, 3(1):19, 1994 Jan-Feb.

6. Smith EL. Commentary on Future directions in the management of non-small cell lung cancer

[original article by Bunn P appears in LUNG CANCER 1993;9(Suppl 2):S91-107]. ONS Nursing

Scan in Oncology, 3(1):19,1994 Jan-Feb.

7. Smith EL. Commentary on Extensive small cell lung cancer [original article by Comis R appears in

LUNG CANCER 1993;9(Suppl 1):S27-39]. ONS Nursing Scan in Oncology, 3(2):18, 1994 Mar-

Apr.

http://www.wect.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.wect.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://drugpolicycentral.com/bot/article/webmd8277.htm

http://www.wate.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.wate.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.wgem.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.wgem.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.cbsatlanta.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.cbsatlanta.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://article.wn.com/view/2012/06/04/Antidepressant_Cymbalta_Might_Ease_ChemoLinked_Pain/

http://article.wn.com/view/2012/06/04/Antidepressant_Cymbalta_Might_Ease_ChemoLinked_Pain/

http://www.fox8live.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.fox8live.com/story/18691536/antidepressant-cymbalta-might-ease-chemo-linked-pain

http://www.ur.umich.edu/update/archives/120606

http://www.cancer.gov/ncicancerbulletin/061212

http://university.asco.org/grant-writing


8. Smith EL. Commentary on The role of respiratory function testing [original article by Pierce R

appears in LUNG CANCER 1993;9:179-84]. ONS Nursing Scan in Oncology, 2(6):16-7, 1993 Nov-

Dec.

9. Smith EL. Commentary on Surgery for small cell lung cancer [original article by Ginsberg R

appears in LUNG CANCER 1993;9:275-80]. ONS Nursing Scan in Oncology, 2(5):17, 1993 Sep-

Oct.

10. Smith EL. Commentary on Is there a role for prophylactic cranial irradiation (PCI) in the

management of small cell lung cancer? [original article by Kristjansen P appears in LUNG

CANCER 1993;9:265-74]. ONS Nursing Scan in Oncology, 2(5):18, 1993 Sep-Oct.

11. Smith EL. Commentary on The role of retinoids in preventing second lung cancers [original article

by Benner S et al appears in LUNG CANCER 1993;9:343-50]. ONS Nursing Scan in Oncology,

2(4):16, 1993 Jul-Aug.

12. Smith EL. Commentary on Chemotherapy versus best supportive care for unresectable non small

cell lungcancer: is it really worthwhile? [original article by Feld R appears in LUNG CANCER

1993;9:391-6]. ONS Nursing Scan in Oncology, 2(4):17, 1993 Jul-Aug.

13. Smith EL. Commentary on How to optimize the use of chest irradiation in small cell lung cancer?

[original article by Benk V et al appears in LUNG CANCER 1992;8:169-173]. ONS Nursing Scan

in Oncology, 2(3):13, 1993 May-Jun.

14. Smith EL. Commentary on The role of colony stimulating factors as an adjunct to lung cancer

chemotherapy: a commentary [original article by Crawford J et al appears in LUNG CANCER

1992;8(3,4):153-8]. ONS Nursing Scan in Oncology, 2(2):13, 1993 Mar-Apr.

15. Smith EL. Commentary on Malignant mesothelioma: prognostic factors in a prospective study of

98 patients [original article by Tammilehto L appears in LUNG CANCER 1992;8(3/4):175-84].

ONS Nursing Scan in Oncology, 2(2):17, 1993 Mar-Apr.

16. Smith EL. Commentary on The newly registered nurse and the cancer patient: an educational

evaluation [original article by Corner J et al appears in INTL J NURS STUD 1992;29(2):177-90].

ONS Nursing Scan in Oncology,1(3):21, 1992 Sep-Oct.

17. Smith EL. Commentary on Long-term survival of "extensive" small cell lung cancer by combined

treatment modalities [original article by Cha R et al appears in LUNG CANCER 1992;8:101-6].

ONS Nursing Scan in Oncology, 2(1):14, 1993 Jan-Feb.

18. Smith EL. Commentary on Treatment of non-small cell lung cancer: new cytostatic agents [original

article by Sorensen J appears in LUNG CANCER 1994;10(3,4):173-87]. ONS Nursing Scan in

Oncology, 3(4):15, 1994 Jul-Aug.

19. Smith EL. Commentary on Biology of lung cancer [original article by Stahel R appears in LUNG

CANCER1994;10(Suppl1):S59-65]. ONS Nursing Scan in Oncology, 3(5):15, 1994 Sep-Oct.

20. Smith EL. Commentary on Does adjuvant chemotherapy decrease distant metastasis formation in

patients with on-small cell lung cancer? [original article by Green M appears in LUNG CANCER

1994;10(Suppl1):S187-94]. ONS Nursing Scan in Oncology, 3(6):18, 1994 Nov-Dec.

21. Smith EL. A Step Forward for Cooperative Group Cancer Nursing Research. The CAL-GAB,

11(3):1,4, 7, 2002 Summer.

22. Smith, E. M. L. (2010). Commentary on Chemotherapy-induced peripheral neuropathy in cancer

survivors [original article by Boland, B. A., Sherry, V., & Polomano, R. C. appears in ONCOLOGY

Nurse Edition 2010 23(2), 1-8]. Helping patients to cope with CIPN. ONCOLOGY Nurse Edition.

23(2), 8-9.


23. dKnoerl, R., Kanzawa, G., & Smith, E. M. L. (2015). Chemotherapy-induced peripheral

neuropathy: Answering your questions about this common nerve condition caused by chemotherapy

treatment. Coping with Cancer. September/October, 10.

a) Featured on Coping with Cancer Website Homepage January 2016;

http://copingmag.com/cwc/index.php/feature_article/chemotherapy_induced_peripher

al_neuropathy

b) Featured on https://www.facebook.com/CopingWithCancer and

https://www.twitter.com/Coping_Cancer

Abstracts

1. a,bMeehan, K., Zacharski, L., Eaton, W., Smith, E., Hammond, S., & Maurer, L. H. (1993). A

phase I-II pilot study evaluating urokinase and warfarin with cisplatin and etoposide in small cell

lung carcinoma. (Abstract 1199). Program/Proceedings of the American Society of Clinical

Oncology, 12.

2. a,bDavis, T. H., Maurer, L. H., Titus-Ernstoff, L., Smith, E., Hammond, S., Doolittle, M., West, P.,

Nelson, E., and The Northern New England Cancer Consortium: DHMC, Lebanon, NH. (1995).

Use of clinical trials for education of community physicians. (Abstract 17) Journal of Cancer

Education, 10(Suppl. 3), 13.

3. aSmith, E. L., O’Donnell, J., Coburn, K. M., Hunt, J. M., Meyer, L. P., Simon, R. M., Sleeth, M.

K., Shamos, E. F., & Youells, F. E. (1996). Patient education improvement efforts at a

comprehensive cancer center. (Abstract 90). Journal of Cancer Education, 11(Suppl. 3), 33.

4. a,bSmith, E., Whedon, M., Bookbinder, M., Fadul, C., Meyer, L., Fanciullo, G., Rose, R., Deleo, J.,

Maurer, L.H., Mills, L., Ahles, T., Plunket, M., Drake, C. (1999). A Multidisciplinary Quality

Improvement Approach to Improve Neuropathic Pain Management in Cancer Patients. (Abstract 4).

Program Proceedings of 2nd International Conference on Mechanisms and Treatment of

Neuropathic Pain, Washington, D.C.

5. a,bSmith, E., Meyer, L., Whedon, M., Bookbinder, M., Fadul, C., Fanciullo, G., Rose, R., Deleo, J.,

Maurer, L.H., Mills, L., Ahles, T., Plunket, M., Drake, C. (2000). A Multidisciplinary Quality

Improvement Approach to Improve Neuropathic Pain Management in Cancer Patients. Poster

presentation at the Oncology Nursing Society Annual Conference.

6. a,bSmith, E. L., Meyer, L., Bakitas, M., Bookbinder, M., Homel, P., Fadul, C., Kingman, L. (2005).

Effects of a Neuropathic Pain Algorithm on Patient and Nursing Outcomes. Poster presentation at

8th International Conference on the Mechanisms and Treatment of Neuropathic Pain, San Francisco,

CA.

7. a,bBeck, S. L., Berry, P., Brant, J., Smith, E., & Towsley, G. (2007). Content validity of the Pain

and Nursing Care Quality (PANCQ) Survey. Oncology Nursing Forum, 34(2), 516.

8. a,bSmith, E. L., Meyer, L. P., Bakitas, M., Homel, P., Kingman, L., Fadul, C. E., & Bookbinder, M.

(May 2008). The Influence of Improved Neuropathic Pain Screening, Assessment, and Treatment

on Patient and System Outcomes. Oncology Nursing Forum, 35, (3), 510. Poster presentation at

Oncology Nursing Society Congress, Atlanta, GA.

9. a,bSmith, E. L., Cohen, J., Pett, M., & Beck, S. L. (2008). Clinimetric Properties of Chemotherapy-

Induced Peripheral Neuropathy (CIPN) Measurement Approaches. Poster presentation at 22nd

Annual Neuroscience Day, Dartmouth College.

10. a,bBeck, S. L., Berry, P., Towsley, G., Brant, J., & Smith, E. L. (2008). Development of the Pain

and Nursing Care Quality (PaNCQ) Survey: Phase 3. Poster presentation at the Western Institute of

Nursing Research Conference.

http://copingmag.com/cwc/index.php/feature_article/chemotherapy_induced_peripheral_neuropathy

http://copingmag.com/cwc/index.php/feature_article/chemotherapy_induced_peripheral_neuropathy

https://www.facebook.com/CopingWithCancer


11. aSchaal, A., DiSalvo, W., Scott, M., Gates, C., Urquhart, L., Skalla, K., & Smith, E. (2008).

Creating and Implementing Transitional Care Summaries. (Abstract 3503). Oncology Nursing

Forum, 35, (6), 978. Poster presentation at the Oncology Nursing Society Advanced Practice

Nursing Conference, Seattle, WA.

12. a,bSmith, E. L., Cohen, J. A., Pett, M. A., & Beck, S. (Accepted 2008 – Declined presentation).

Clinimetric Properties of Chemotherapy-Induced Peripheral Neuropathy (CIPN) Measurement

Approaches. Oncology Nursing Society Advanced Practice Nursing Conference, Seattle, WA.

13. a,bGuo, JW, Pett, M, Beck, SL, Towsley, GL, Brant, J, Smith, EL, Berry, P. (2009) Confirmatory

Factor Analysis of the Pain Care Quality Survey. Poster presentation at the Society for Behavioral

Medicine Conference, Montreal, Canada.

14. a,bDonovan, H.S., Nolte, S., Pipe, T., Ulrich, C., Hooke, C., Lillington, L., Hinds, P., Barton, D.,

Homan, S., Smith, E.M.L., Bruner, D., & Mallory, G. (2009). ONS Foundation Multisite Research

Training Program: Lessons Learned Two Years Out. (Abstract 3900). Poster presentation at the

Oncology Nursing Society Congress.

15. a,bSkalla, K., Smith, E. L., Anton, K., Gallagher, S., Onega, T., & Dietrich, A. (2010). Statewide

Cancer Survivor Web Survey: A Translational Research Method (Abstract 4293). Poster

presentation at the Oncology Nursing Society Congress, San Diego, CA.

16. a,bSmith, E.L., Skalla, K., Onega, T., Anton, K., Gallagher, S., Rhoda, J., DiSalvo, W., & Dietrich,

A. (2010). The cancer survivor survey: Using web-based technology to assess cancer survivor

challenges (Abstract 9054). Proceedings of the American Society of Clinical Oncology, 28(Suppl.

15).

17. a,bBrant, J. M., Towsley, G. L., Berry, P., Beck, S. L., Smith, E., Pett, M. A., Guo, J. W., &

Donohue, R. B. (2010). Nurses’ Knowledge and Attitudes about Pain Management: Certification

Makes a Difference 2010 Poster presentation at the Council for the Advancement of Nursing Science

Meeting, Washington, D.C.

18. a,bThornton, D., Smith, E. L., Skalla, K., Li, Z., Onega, T., Anton, K., Gallagher, S., Rhoda, J.,

DisSalvo, W., & Dietrich, A. (2011). Using web-based technology to assess psychological distress

experienced by breast cancer survivors across the survivorship continuum. Poster presentation at the

University Of Michigan School Of Nursing Dean’s Research Day. Ann Arbor, MI. Received 3rd

place award for best poster presentation. (Faculty mentor for Thornton).

19. a,bCook, T, Katapodi, M. C., Smith, E. L., Pierce, P. F., Northouse, L. L., Liu, G., Milliron, K., &

Merajver, S. D. (2011). Decisional Conflict and Family Communication in Genetic Testing for

Hereditary Breast and Ovarian Cancer. Poster presentation at the Midwest Nursing Research

Society Annual Conference, Columbus, OH.

20. a,bTowsley, G., Guo, J., Brant, J., Smith, E., Perry, P., Pett, M., & Beck, S. (2012). Predictors of

Pain in Older Hospitalized Cancer Patients. Gerontological Society of America 65th Annual

Scientific Meeting, San Diego, CA.

21. Smith, E. L. (2012). Plagiarism. MICHR Annual Research Education Symposium: Ann Arbor, MI

22. a,bSmith, E. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Fadul, C., Knox,



induced peripheral neuropathy (CIPN). (Abstract 91721). Proceedings of the American Society of

Clinical Oncology (ASCO). Accepted for Scientific Symposium Presentation and ASCO Press

Program Presentation.

Selected to be included in the Best of ASCO® program. The Best of ASCO® is an educational

initiative that condenses highlights from ASCO’s Annual Meeting into a two-day program. The


purpose of this initiative is to increase global access to cutting-edge science. Abstracts were

selected according to specific criteria and reflect research that is relevant and significant in

oncology today. In addition to three domestic Best of ASCO® meetings, there will also be

approximately fifteen International Best of ASCO® Meetings.

23. a,bSmith, E. L., Renbarger, J., Hutchinson, R., Wells, E., Ho, R., & Burnette, W. B. (2012).

Measuring Vincristine-Induced Peripheral Neuropathy in Children. Accepted for podium

presentation at the Connections: Advancing Care through Science Conference in Phoenix, Arizona

on November 16-18, 2012.

24. a,b Smith, E. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Fadul, C., Knox,



induced peripheral neuropathy (CIPN). Invited podium and abstract; American Society of

Hematology (ASH).

25. a,b Towsley, G. L., Guo, J., Brant, J., Smith, E., Berry, P. H., Pett, M., Beck, S. (2012). Predictors of

pain intensity in older hospitalized cancer patients. Gerontologist, 52, 568-569.

26. a,bSmith, E. L., Li, L., Hutchinson, R., Ho, R., Burnette, W. B., Wells, E., Bridges, C., Kelly, J. P,

Thomas, K. & Renbarger, J. (2013). Measuring Vincristine-Induced Peripheral Neuropathy in

Children. Abstract and poster presented at University of Michigan MICHR Research Symposium

and the School of Nursing’s Dean’s Research Day - Received 1st prize award on Dean’s Research

Day.

27. a,b Berezovsky, A., Sengupta, M., Brummett, C., Henry, L., Harte, S., Williams, D., Tsodikov, A.,

Bridges, C., Kolarik, E., & Smith, E. L. (2013). Does a pain prone phenotype predict post breast

cancer pain? Abstract & poster presented at University of Michigan MICHR Research Symposium.

28. a,b Thomas, K., Smith, E. L., Li, L., Hutchinson, R. J., Wells, E., Ho, R., Burnette, W. B.,

Robertson, P. L., Bridges, C., Kelly, J. P., Knoerl, R., Chiang. C. W., & Renbarger. (2014).

Describing the incidence, patterns, and severity of vincristine-induced peripheral neuropathy in

children with acute lymphoblastic leukemia. Abstract & poster presented at University of Michigan

School of Nursing’s Dean Research Day - Received 1st Place Award.

29. abPachman, D., Qin, R., Seisler, D., Smith, E. M. L., Beutler, A. S., Ta, L. E., Lafky, J., Johnston,

N. W., Ruddy, K., Bernath, A. M., Dakhil, S. R., Grothey, A., Loprinzi, C. (In Press). A comparison

of the natural history of oxaliplatin- and paclitaxel-induced neuropathy (NCCTG N08C1,

N08CB/Alliance). American Society of Clinical Oncology.

30. b,dKanzawa, G., Smith, E. L., Brummett, C., Clauw, D., Henry, L.N., Harte, S., Williams, D.

Tsodikov, A., Bridges, C., Kolarik, E., Kelly, J. P., Prasertsri, N., Phligbua, W., Berezovsky, A., &

Sengupta. M. (2015). The Painful Truth: Chronic Neuropathic Pain Patterns in Breast Cancer

Surgery Patients. University of Michigan Dean’s Research Day Poster Presentation. Ann Arbor, MI.

31. b,dKnoerl, R., Smith, E. L. (2015). Chronic Pain and Cognitive Behavioral Therapy: A Literature

Review & Directions for Future Research. University of Michigan Dean’s Research Day Poster

Presentation. Ann Arbor, MI.

32. a,b,dKnoerl, R., Smith, E. L. (2015). Chronic Pain and Cognitive Behavioral Therapy: A Literature

Review & Directions for Future Research. MNRS Doctoral Student Poster Presentation,

Indianapolis, IN.

33. bSchymik, F. A., Voepel-Lewis, T., & Smith, E.L. (2015). Parental Opioid Decision Making for

Children with and without Obstructive Sleep Apnea who underwent Tonsillectomy and

Adenoidectomy. University of Michigan Dean’s Research Day Poster Presentation. Ann Arbor, MI.


34. a,bRuddy, K., Pachman, D. R., Qin, R., Seisler, D., Smith, E. M. L., Puttabasavaiah, S., Novotny,

P., Ta, L. E., Beutler, A. S., Johnston, N. D. W., Staff, N., Grothey, A., Dakhil, S., Loprinzi, C. L.

(2015). A comparison of the natural history of Oxaliplatin- and Paclitaxel-induced neuropathy –

N08C1, N08CB (Alliance). American Society of Clinical Oncology.

35. a,bErickson, J. M., Brant, J. M., Smith, E. L., & Beck, S. L. (2015) The Pain Experience of

Hospitalized Young Adults with Cancer. Poster Presentation. Critical Mass Young Adult

Conference, Chicago, IL. Received third place poster award.

36. a,bSmith, E. M. L., Yang, J., Banerjee, T., Loprinizi, C., Cavaletti, G., Bridges, C., Haupt, R.,

Kanzawa, G., Knoerl, R., Lee-Ekblad, D., Prasertsri, N. (2016). The reliability, validity, and

sensitivity of the European Organization for Research and Treatment of Cancer (EORTC) Quality of

Life Questionnaire-chemotherapy-induced Peripheral Neuropathy (QLQ-CIPN-20). Podium

Symposium Presentation – Midwestern Nursing Research Conference, Milwaukee, WI. March 2016.

37. a,b,d Knoerl, R., Bridges, C., Smith, G., Scheu, K., Prasertsri, N., Phligbua, W., Kanzawa, G., Haupt,

R., Lee-Ekblad, D., Still, N., & Smith, E. M. L. (2016). Pilot testing a web-based system for

assessment and management of chemotherapy-induced peripheral neuropathy. Symposium

Presentation – Midwestern Nursing Research Conference, Milwaukee, WI. March 2016.

38. a,b,d Kanzawa, G., Bridges, C., Prasertsri, N., Kelly, J., Phligbua, W., Berezovsky, A. & Smith, E.

M. L. (2016). The Painful Truth: Chronic neuropathic pain and chemotherapy-induced peripheral

neuropathy in breast cancer surgery patients – Midwestern Nursing Research Conference,

Milwaukee, WI. March 2016.

39. a,b,d Lee, D., Bridges, C., Knoerl, R., Kanzawa, G., Smith, G., Scheu, K., Still, N., & Smith, E. M.

L. (2016). Symptom reporting, monitoring, and management for breast cancer patients using the

web-based OnQ care planning system – Midwestern Nursing Research Conference, Milwaukee, WI.

March 2016.

40. a,b,d Kanzawa, G., & Smith, E. M. L. (2016). The effects of exercise and physiotherapy on

peripheral neuropathy: A literature review. Poster Presentation - Midwestern Nursing Research

Conference, Milwaukee, WI. March 2016.

41. a,b,d Lee, D., Haupt, R., Kelly, J. P., Donohue, C., & Smith, E. M. L. (2016). Cognitive Interviewing

Approaches for Assessing Content Validity – Poster Presentation – Dean’s Research Day, Ann

Arbor, MI. April 2016.

42. a,b,d Kippe, K., Knoerl, R., & Smith, E. M. L. (2016). Electronic versus Paper-Pencil Methods for

Assessing Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic Pain – Poster

Presentation – Dean’s Research Day, Ann Arbor, MI. April 2016.

43. Kanzawa, G., Harte, S.E., Brummett, C., Clauw, D.J., Williams, D.A., Tzodikov, A., Halvorson,

M.E., Kolarik, E., Kelly, J.P. IV, Bridges, C. M., Smith, E. L. (2016). Comparing Pain Sensitivity

Subgroups in Women before Breast Cancer Surgery – Poster Presentation – Dean’s Research Day,

Ann Arbor, MI. April 2016.

44. Ross, W., Smith, E., Ho, R., Wells,E., Sadjdk,T., Tehn, J., Li, L., Renbarger, J. (2016). Potential

Biomarkers for Early Detection of Neuropathy in Pediatric ALL Patients. (Abstract). Society of

Neuroscience, November, 2016.

45. a,b.dKnoerl, R., Yang,. J., Barton, D. L., Williams, D. A., Holden, J. E., Krauss, J. C., Bridges, C.,

Smith, E. M. L. (2017). Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-

Induced Peripheral Neuropathy: A Multicenter, Single Blind, Randomized, Wait-List Controlled

Trial. (Abstract). American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, IL,

June, 2017.


46. a,b Knoerl, R., Smith, E. M. L., & Chornoby, Z. Estimating the Frequency, Severity, and Clustering

of SPADE Symptoms in Chronic Painful Chemotherapy Induced Peripheral Neuropathy (CIPN).

2018. (Abstract). American Pain Society Conference. Anaheim California, March 2018.

47. a,dDonohoe, C., Smith, E. L. (2018). Mental Health Predictors of Pain in Children and Adolescents

with Sickle Cell Disease (Abstract/Poster). Association of Pediatric hematology/Oncology Nurses

Annual Conference, Savannah, Georgia, September, 2018.

48. a,b,e Wagner, M. A., Smith, E. L., & Holden, J. E. (2018). Effectiveness of Duloxetine in Preventing

Painful CIPN (Abstract). Council for the Advancement of Nursing Science. September, 2018.

Washington, D.C. Accepted for podium presentation.

49. Wagner. M. A., Wickersham, K. E., Lassiter, C. B., Smith, E. M. L., Holden, E., & Dorsey, S. G.

(2018). Transcriptomic Profile of the Lateral Hypothalamus in the Development of Painful

Chemotherapy-induced Peripheral Neuropathy Before and After Cisplatin Treatment in Mice.

(Abstract/Poster). International Society of Nurses in Genetics. October, 2018. Orlando, Florida.

50. a,b,dKanzawa-Lee, G. A., Harte, S. E., Bridges, C. M., Brummett, C. M., Clauw, D. J., Williams, D.

A., Knoerl, R., Smith, E. M. L. (2017). Childhood Trauma and Cancer Treatment-Related Pain in

Breast Cancer Survivors. (Abstract/Podium). International Conference on Cancer Nursing, Anaheim,

CA, July 2017.

51. a,b.dKnoerl, R., Lee, D., Dudley, W. N., Smith, G., Bridges, C. M., Smith, E. M. L. (2017).

Examining the Impact of a Web-Based Cancer Care Planning System to Promote Patient Activation.

(Abstract/Podium). International Conference on Cancer Nursing, Anaheim, CA, July 2017.

52. a,bSmith, E. M. L., Yang, J. J., Bridges, C. M., Banerjee, T., Knoerl, R., Kanzawa-Lee, G., Lee, D.,

Haupt, R., Prasertsri, N., Alberti, P., Donohoe, C., Edwards, E., Loprinzi, C. (2017). Chemotherapy-

Induced Peripheral Neuropathy (CIPN) Measurement Using a Patient-Reported Outcome Measure.

(Abstract/Podium). International Conference on Cancer Nursing, Anaheim, CA, July 2017.

53. a,b,d,e Prasertrsi, N., & Smith, E. M. L. (2018). Feasibility, Usability and Acceptability of

Chemotherapy-Induced Pain and Neuropathy Mobile Application (mCIPN app) Educational

Teaching Approach for Nurses to Enhance Knowledge, Assessment, and Symptom Management

(Abstract). International Association for the Study of Pain. Boston, MA, September 2018.

54. a,b.eKnoerl, R., Smith, E. M. L., Han, A., Doe, A., Scott, K., & Berry, D. L. (2019). Characterizing

Patient-Clinician Chemotherapy-Induced Peripheral Neuropathy Assessment and Management

Communication Approaches. Abstract/Poster presented at the Oncology Nursing Society Congress,

Anaheim California, April, 2019.

55. a,b.d,eKanzawa-Lee, G., Krauss, J.; Larson, J., Ploutz-Snyder, R., Resnicow, K., & Smith, E. M. L.

(2019). Walking to Reduce Chemotherapy-Induced Peripheral Neuropathy: A Pilot Feasibility RCT

Abstract/Poster presented at the Oncology Nursing Society Congress, Anaheim California, April,

2019.

56. a,bMarcath, L. A., Kdwell, K. M., Smith, E. M. L., Vangipuram, K., Gersch, C., Burness, M. L.,

Griggs, J. J., Schott, A. F., Van Poznak, C., Hayes, D. F., Henry, N. L., Beutler, A. S., & Hertz, D.

L. EPHA genetics for prediction of paclitaxel-induced peripheral neuropathy sensitivity. (2019).

American Society of Clinical Oncology.

57. a,bJennaro, T. S., Smith, E. M. L., Vangipuram, K., Kidwell, K. M., Burness, M. L., Griggs, J. J.,

Van Poznak, C. H, Hayes, D. F., Henry, N. L., & Hertz,, D. L. (2019). Vitamin D insufficiency and

risk of paclitaxel-induced peripheral neuropathy. American Society of Clinical Oncology.

58. Woo, S., Veliz, P., Smith, E. L., Saint Arnault, D. M., Earl, A., Struble, L. M., & Larson, J. L.

(2020). Development and psychometric evaluation of the COPD-related Stigma Scale. Midwest

Nursing Research Society Annual Conference April 1-4, 2020. Schaumburg, IL.


59. a,b,d,eKanzawa-Lee, G., Larson, J., Ploutz-Synder, R., Kraus, J., Resnicow, K., & Smith, E. M. L.

(2020). Moderate to Vigorous Physical Activity Feasibility in Chemotherapy-receiving

Gastrointestinal Cancer Suvivros. (Abstract). American College of Sports Medicine Annual

Meeting, May 26-30, 2020. San Francisco, CA.

International Abstract Presentations

1. a,bMaurer, L. H., Lewis, L., Rigas, J., Beaulieu, B., Nierenberg, D., Smith, E., Meyer, L., &

Hammond, S. (1997). The effect of paclitaxel scheduling on the pharmacokinetics of ifosfamide in

patients with lung cancer. (Abstract 151). Lung Cancer, 18(Suppl. 1), 41. Poster presentation at the

International Lung Cancer Society Conference, Dublin, Ireland.

2. a,bRigas, J., Leopold, K., Maurer L. H., Eaton W., Black, W., Smith, E., Meyer, L., & Hammond. S.

(1997). Daily paclitaxel and thoracic radiation for the treatment of stage II-IIIB NSCLC. (1997).

(Abstract 268). Lung Cancer, 18(Suppl. 1), 70. Poster presentation at the International Lung Cancer

Society Conference, Dublin, Ireland.

3. a,bMaurer, L. H., West, P., Eaton, W., Rigas, J., Leopold, K., Hammond, S., & Smith E. (1997).

Small cell lung cancer: 25 year experience from the Dartmouth Hitchcock medical center (DHMC):

How much has changed. (Abstract 44). Lung Cancer, 18(Suppl. 1), 14. Poster presentation at the

International Lung Cancer Society Conference, Dublin, Ireland.

4. a,bMeyer, L, Rigas, J., Hoopes, J., Leopold, K., Maurer, L. H., Eaton, W., Smith E., & Hammond S.

(1997). Fatigue and plasma cytokines in patients treated with combined modality therapy for non-

small cell lung cancer (NSCLC). (Abstract 792). Lung Cancer, 18(Suppl. 1), 204. Poster

presentation at the International Lung Cancer Society Conference, Dublin, Ireland.

5. a,bSmith, E. L., Hann, D., Ahles, T., Furstenberg, T., Mitchell, T., Meyer, L. Maurer, L. H., &

Rigas, J. (1997). Quality of life and dyspnea in lung cancer patients. (Abstract 795). Lung Cancer,

18(Suppl. 1), 205. Poster presentation at the International Lung Cancer Society Conference, Dublin,

Ireland.

6. a,bBakitas, M. A., Smith, E., Cohen, J., & Fadul, C. (2004, November 4-6). Measurement issues in

chemotherapy-induced peripheral neuropathy. Poster presentation at the International Conference

on the Mechanisms and Treatment of Neuropathic Pain, Bermuda.

7. Mulrooney, T., Disalvo, W., Gillock, K., Smith, E. L., Ludy, L., Schaal, A. D., Scott, M., & Meyer,

L. (2006). “Survive and Thrive: The APN Cares Clinic”: Development of an Advanced Practice

Nurse-Led Cancer Survivors Clinic in Rural Northern New England. Poster presentation, Italy.

8. a,bSmith, E. M. L., Lang, L., Ho, R., Wells, E. M., Hutchinson, R. J., Skiles, J., Chakraborty, A.,

Wei, C., Thomas, K., & Renbarger, J. (2014). Standing on Pins and Needles? Patterns and severity

of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia during

the first year of treatment. (Abstract Podium Presentation). International Society of Pediatric

Oncology Annual Conference, Toronto, Canada.

9. a,b,d Prasertrsi, N., Smith, E. M. L., Kaewmanee, C., Phanatchaya, K., & Munaudsa, B. (2016).

Chemotherapy-induced pain and neuropathy: A cross-sectional study in Thai Cancer Patients

(Abstract). International Association for the Study of Pain. Yokohma, Japan.

Papers and Abstracts Under Review.

1. a,bSalgado, T. M., Reed, H. L., Quinn, C., Syverson, J. G., Liu, J., Le-Rademacher, Farris, K. B.,

Vangipuram, K., Smith, E. M. L., Henry, N. L., & Hertz, D. L. (Under Review). Patient factors

associated with discrepancies between patient-reported and clinician-documented peripheral

neuropathy in women with breast cancer receiving paclitaxel. Cancer Nursing.


2. a, bJennaro, T., Fanf, F., Kidwell, K. M., Smith, E. M. L., Vangipuram, K., Burness, M., Griggs, J.

J., Van Poznak, C., Hayes, D. F., Henry, N. L., & Hertz, D. L. (Under Review). Vitamin D

deficiency increases severity of paclitaxel-induced peripheral neuropathy. International Journal of

Cancer.

3. a,b,d,eSmith, E. M. L, Kuisell, C., Kanzawa-Lee, G., Cho, Y., R., Bridges, C. M., & Gilchrist, L. S.

(Under Review). Pediatric Assessment of Chemotherapy-Induced Peripheral Neuropathy Using a

Patient-Reported Outcome Measure: The P-CIN Measure. Abstract. Oncology Nursing Society

Annual Congress, April 29 – May 3, 2020. San Antonio, TX.



Patient-Reported Outcome Measure: The P-CIN Measure. Abstract. University of Michigan

Research Day 2020.



Patient-Reported Outcome Measure: The P-CIN Measure. Abstract. Peripheral Nerve Society

Annual Congress, June 27 – 30, 2020. Miami, FL.

7. a,eSmith, A., Umberfield, E., Granner, J., Harris, M., Shuman, C., Liestenfeltz, B., & Smith, E. M.

L. (Under Review). Development of the Collaboration for Innovation in Mentoring (CLIM) Survey:

A Measure of PhD Mentorship Quality in Nursing. Abstract. Midwest Nursing Research Society

Annual Conference April 1-4, 2020. Schaumburg, IL.

8. a,eSmith, A., Umberfield, E., Granner, J., Harris, M., Shuman, C., Liestenfeltz, B., & Smith, E. M.

L. (Under Review). Development of the Collaboration for Innovation in Mentoring (CLIM) Survey:

A Measure of PhD Mentorship Quality in Nursing. Abstract. University of Michigan Research Day

2020. Ann Arbor, MI.

9. a,b,d,eKanzawa-Lee, G., Larson, J., Ploutz-Synder, R., Kraus, J., Resnicow, K., & Smith, E. M. L.

(Under Review). Moderate to Vigorous Physical Activity Effect on Chemotherapy-Induced

Peripheral Neuropathy. (Abstract). American Society of Clinical Oncology Annual Meeting, May

29- June 2, 2020. Chicago, IL.

10. a,bLoprinzi, C.L., Lacchetti, C., Bleeker, J., Cavaletti, G., Chauhan, C., Hertz, D., Kelley, M. R.,

Lavino, A., Lustberg, M. B., Paice, J., Schneider, B. P., Smith, E. M. L., Smith, M. L., Smith, T.,

Terstriep, S., Wagner-Johnston, N., & Hershman. D. L. (Under Review). Prevention and

management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO

Clinical Practice Guideline Update. Journal of Clinical Oncology.

Papers and Abstracts in Preparation

1. a,b,d Prasertsri, N., Smith, E.M. L. The reliability and validity of the European Organization for

Research and Treatment of Cancer QLQ-CIPN20 Thai version.

2. a,b,e Wagner, M. A., Dorsey, S. G., Wickersham, K. E., Smith, E. L., Burke, D., & Holden, J. E. (In

Preparation). The Role of the Gene Expression in the Lateral Hypothalamus on the Development of

Allodynia After Cisplatin Treatment.

3. a,bAlbany, C., Dockter, T., Wolfe, E., LeRademacher, J., Wagner-Johnston, N., Einhorn, L., Hanna,

N., Lafky, J., Smith, E., Pachman, D., Staff, N., Loprinzi, C. L., & Costello, B. (In Preparation)

Cisplatin-associated neuropathy characteristics compared to other neurotoxic chemotherapy agents.

Supportive Care Cancer.


4. a,b,d,eSmith, E. M. L., Donohoe, C., . . . (In Preparation). The Pediatric Chemotherapy-Induced

Neuropathy (P-CIN) patient-reported outcome measure: Results of preliminary psychometric testing.

5. aSmith, E. M. L., Weickel, R., Ploutz-Synder, R., Arslanian-Engoren, C., Lori, J., plus other, &

Thomas, L. (In Preparation). Using an Appreciative Inquiry Framework to Modernize Doctoral

Education in Nursing. Nursing Outlook.

6. a,eSmith, A. B., Shuman, C., Granner, J., Liestenfeltz, B., Harris, M., & Smith, E. M. L. (In

Preparation). Collaboration for Leadership and Innovation in Mentoring (CLIM): A tool for

measuring nursing PhD mentor/mentee relationship metrics.

ellen m. lavoie smith, phd, msn, rn, aocn®, faan education

Documents